<?xml version="1.0" encoding="utf-8"?><feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><generator uri="https://jekyllrb.com/" version="4.3.4">Jekyll</generator><link href="https://kuchikinamthip.github.io/feed.xml" rel="self" type="application/atom+xml"/><link href="https://kuchikinamthip.github.io/" rel="alternate" type="text/html" hreflang="en"/><updated>2025-09-26T04:10:42+00:00</updated><id>https://kuchikinamthip.github.io/feed.xml</id><title type="html">The Whispers of Biology</title><subtitle>Cool Website &amp; Blog written by NAMTHIP. </subtitle><entry><title type="html">‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏¢‡∏±‡∏á‡∏ô‡πà‡∏≤‡∏´‡∏•‡∏á‡πÉ‡∏´‡∏•‡πÅ‡∏•‡∏∞‡∏™‡∏ß‡∏¢‡∏á‡∏≤‡∏°‡∏≠‡∏¢‡∏π‡πà‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà?</title><link href="https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_18.html/" rel="alternate" type="text/html" title="‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏¢‡∏±‡∏á‡∏ô‡πà‡∏≤‡∏´‡∏•‡∏á‡πÉ‡∏´‡∏•‡πÅ‡∏•‡∏∞‡∏™‡∏ß‡∏¢‡∏á‡∏≤‡∏°‡∏≠‡∏¢‡∏π‡πà‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà?"/><published>2025-09-18T09:27:00+00:00</published><updated>2025-09-18T09:27:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_18.html</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_18.html/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏¢‡∏±‡∏á‡∏ô‡πà‡∏≤‡∏´‡∏•‡∏á‡πÉ‡∏´‡∏•‡πÅ‡∏•‡∏∞‡∏™‡∏ß‡∏¢‡∏á‡∏≤‡∏°‡∏≠‡∏¢‡∏π‡πà‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà?‡πÇ‡∏Ñ‡∏ß‡∏¥‡∏î‡∏û‡∏£‡∏≤‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏∏‡∏Ç ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡∏±‡πà‡∏ô‡∏Ç‡∏≠‡∏á‡πÄ‡∏£‡∏≤‡πÑ‡∏õ‚Ä¶‡πÄ‡∏ó‡πà‡∏≤‡πÑ‡∏´‡∏£‡πà‡πÅ‡∏•‡πâ‡∏ß.‡∏ô‡∏µ‡πà‡∏Å‡πá‡πÄ‡∏ô‡∏¥‡πà‡∏ô‡∏ô‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏ò‡∏£‡∏£‡∏°‡∏î‡∏≤‡πÜ‡∏´‡∏≤‡∏¢‡πÑ‡∏õ ‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏ß‡∏µ‡πà‡πÅ‡∏ß‡∏ß‡∏ß‡πà‡∏≤‡πÄ‡∏°‡∏∑‡πà‡∏≠‡πÑ‡∏´‡∏£‡πà‡∏à‡∏∞‡∏Å‡∏•‡∏±‡∏ö‡∏°‡∏≤.‡πÇ‡∏£‡∏Ñ‡∏†‡∏±‡∏¢‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÇ‡∏Ñ‡∏ß‡∏¥‡∏î‡πÄ‡∏õ‡πá‡∏ô‡∏™‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ö‡∏ß‡∏á‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡πÅ‡∏•‡∏∞‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡πÇ‡∏î‡∏¢‡∏ï‡∏£‡∏á‡∏Ñ‡∏ô‡∏´‡∏±‡∏ô‡∏°‡∏≤‡∏™‡∏ô‡πÉ‡∏à‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏ä‡∏¥‡πâ‡∏ô‡πÅ‡∏•‡πâ‡∏ß‡∏ä‡∏¥‡πâ‡∏ô‡πÄ‡∏•‡πà‡∏≤‡∏ó‡∏µ‡πà‡∏ñ‡∏π‡∏Å‡∏ö‡∏≠‡∏Å‡πÄ‡∏•‡πà‡∏≤‡∏ú‡πà‡∏≤‡∏ô‡∏õ‡∏≤‡∏Å‡∏Ç‡∏≠‡∏á‡∏ô‡∏±‡∏Å‡∏ß‡∏¥‡∏ä‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡∏î‡∏±‡∏á‡∏ö‡πâ‡∏≤‡∏á ‡πÄ‡∏ö‡∏≤‡∏ö‡πâ‡∏≤‡∏á‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡πÑ‡∏î‡πâ‡∏ö‡πâ‡∏≤‡∏á ‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ö‡πâ‡∏≤‡∏á .‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏ó‡∏µ‡πà‡πÅ‡∏™‡∏ô‡∏à‡∏∞‡∏™‡∏ß‡∏¢‡∏á‡∏≤‡∏°‡∏ß‡πà‡∏≤‡∏Ñ‡∏ß‡∏≤‡∏°‡∏Å‡∏±‡∏ô‡∏ï‡∏≤‡∏°‡∏´‡∏•‡∏±‡∏Å‡∏ê‡∏≤‡∏ô‡πÄ‡∏ä‡∏¥‡∏á‡∏õ‡∏£‡∏∞‡∏à‡∏±‡∏Å‡∏©‡πå‡∏ñ‡∏π‡∏Å‡∏ô‡∏≥‡∏°‡∏≤‡∏ñ‡∏Å‡πÄ‡∏ñ‡∏µ‡∏¢‡∏á‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏´‡∏ï‡∏∏‡∏ú‡∏•‡∏ó‡∏µ‡πà‡∏ï‡πà‡∏≤‡∏á ‡∏ä‡∏ß‡∏ô‡πÉ‡∏´‡πâ‡∏™‡∏ô‡πÉ‡∏à‡πÉ‡∏ô‡∏°‡∏∏‡∏°‡∏°‡∏≠‡∏á‡πÅ‡∏ï‡πà‡∏Å‡∏•‡∏±‡∏ö‡∏Å‡∏•‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡∏ó‡∏µ‡πà‡πÅ‡∏ï‡∏Å ‡∏Ç‡πâ‡∏≠‡∏™‡∏£‡∏∏‡∏õ‡∏ó‡∏µ‡πà‡πÄ‡∏Å‡∏¥‡∏î‡∏Ç‡∏∂‡πâ‡∏ô‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡πÑ‡∏î‡πâ‡∏ï‡∏≤‡∏°‡πÅ‡∏ï‡πà‡∏•‡∏±‡∏ó‡∏ò‡∏¥‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏ä‡∏∑‡πà‡∏≠.‡∏ö‡πâ‡∏≤‡∏á‡∏ß‡πà‡∏≤‡∏Å‡∏±‡∏ô‡∏ï‡∏≤‡∏°‡∏´‡∏•‡∏±‡∏Å‡∏ê‡∏≤‡∏ô‡∏ó‡∏≤‡∏á‡∏ß‡∏¥‡∏ä‡∏≤‡∏Å‡∏≤‡∏£‡∏ö‡πâ‡∏≤‡∏á‡∏Å‡πá‡∏Å‡∏•‡πà‡∏≤‡∏ß‡∏ñ‡∏∂‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡∏™‡∏π‡∏ï‡∏£‡∏ß‡∏±‡∏Ñ‡∏ã‡∏µ‡∏ô‡πÉ‡∏´‡∏°‡πà‡∏ô‡∏µ‡πà‡∏ä‡∏ß‡∏ô‡πÉ‡∏´‡πâ‡∏™‡∏á‡∏™‡∏±‡∏¢‡πÉ‡∏ô‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡πÑ‡∏°‡πà‡∏ô‡πâ‡∏≠‡∏¢‡∏ß‡πà‡∏≤‡∏°‡∏µ‡∏≠‡∏∞‡πÑ‡∏£‡∏≠‡∏¢‡∏π‡πà‡πÉ‡∏ô‡πÉ‡∏à‡∏Ç‡∏≠‡∏á‡∏ô‡∏±‡∏Å‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡πÄ‡∏´‡∏•‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô.‡∏™‡∏¥‡πà‡∏á‡∏ô‡∏±‡πâ‡∏ô‡∏Ñ‡∏∑‡∏≠‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡πÇ‡∏î‡∏¢‡∏ö‡∏£‡∏¥‡∏™‡∏∏‡∏ó‡∏ò‡∏¥‡πå‡πÄ‡∏´‡πá‡∏ô‡πÅ‡∏Å‡πà‡∏°‡∏ß‡∏•‡∏°‡∏ô‡∏∏‡∏©‡∏¢‡πå‡∏à‡∏£‡∏¥‡∏á‡πÜ‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏°‡πà‡∏´‡∏£‡∏∑‡∏≠‡∏°‡∏µ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡πÄ‡∏°‡∏∑‡∏≠‡∏á ‡∏®‡∏±‡∏Å‡∏î‡∏¥‡πå‡∏®‡∏£‡∏µ‡πÄ‡∏Ç‡πâ‡∏≤‡∏°‡∏≤‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á.‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏¢‡∏±‡∏á‡∏ô‡πà‡∏≤‡∏´‡∏•‡∏á‡πÉ‡∏´‡∏•‡∏¢‡∏±‡∏á‡πÄ‡∏õ‡πá‡∏ô‡∏Ñ‡∏ß‡∏≤‡∏°‡∏à‡∏£‡∏¥‡∏á‡∏Ç‡∏≠‡∏á‡∏™‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡πÄ‡∏à‡∏≠‡πÉ‡∏ô‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡πÅ‡∏•‡∏∞‡∏¢‡∏±‡∏á‡∏Ñ‡∏á‡∏Ñ‡∏ß‡∏≤‡∏°‡∏´‡∏ß‡∏±‡∏á‡∏Ç‡∏≠‡∏á‡πÇ‡∏•‡∏Å‡∏≠‡∏¢‡∏π‡πà‡πÑ‡∏´‡∏°?.‡πÉ‡∏ô‡∏ê‡∏≤‡∏ô‡∏∞‡∏ô‡∏¥‡∏ß‡∏ö‡∏µ‡πâ‡∏Ç‡∏≠‡∏á‡∏ß‡∏á‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏Å‡πá‡∏Ñ‡∏á‡πÑ‡∏î‡πâ‡πÅ‡∏ï‡πà‡∏ï‡∏±‡πâ‡∏á‡∏Ñ‡∏≥‡∏ñ‡∏≤‡∏°‡∏ó‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡πÉ‡∏ô‡πÉ‡∏à‡∏Å‡πá‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏à‡∏∞‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡∏±‡πà‡∏ô‡πÑ‡∏õ‡πÄ‡∏™‡∏µ‡∏¢‡πÅ‡∏•‡πâ‡∏ß.‡πÄ‡∏Ñ‡∏¢‡∏Ñ‡∏¥‡∏î‡∏ß‡πà‡∏≤‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏à‡∏∞‚Ä¶‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Ñ‡∏ô‡∏°‡∏µ‡∏ï‡∏£‡∏£‡∏Å‡∏∞‡πÅ‡∏•‡∏∞‡πÄ‡∏´‡∏ï‡∏∏‡∏ú‡∏•‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏à‡∏∞‚Ä¶‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏´‡∏•‡∏≤‡∏¢‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ñ‡∏π‡∏Å‡∏´‡∏¢‡∏¥‡∏ö‡∏¢‡∏Å‡∏°‡∏≤‡∏ñ‡∏Å‡πÄ‡∏ñ‡∏µ‡∏¢‡∏á‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏à‡∏∞‚Ä¶‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Ñ‡∏ô‡πÑ‡∏ó‡∏¢‡πÄ‡∏•‡∏¥‡∏Å‡∏á‡∏°‡∏á‡∏≤‡∏¢.‡πÅ‡∏ï‡πà‚Ä¶‡∏°‡∏±‡∏ô‡∏î‡∏π‡∏¢‡∏≤‡∏Å‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡πÄ‡∏Å‡∏¥‡∏ô‡∏ó‡∏µ‡πà‡∏õ‡∏£‡∏∞‡πÄ‡∏ó‡∏®‡πÑ‡∏ó‡∏¢‡∏à‡∏∞‡∏°‡∏µ‡∏≠‡∏∞‡πÑ‡∏£‡πÅ‡∏ö‡∏ö‡∏ô‡∏±‡πâ‡∏ô‡∏ó‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡∏ô‡∏±‡∏Å‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡πÑ‡∏ó‡∏¢‡πÄ‡∏Å‡πà‡∏á‡πÜ‡∏°‡∏≤‡∏Å‡∏°‡∏≤‡∏¢‡∏°‡∏µ‡∏ä‡∏∑‡πà‡∏≠‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡∏≠‡∏¢‡∏π‡πà‡∏ó‡∏±‡πà‡∏ß‡∏ó‡∏∏‡∏Å‡∏°‡∏∏‡∏°‡πÇ‡∏•‡∏Å‡∏ö‡πâ‡∏≤‡∏á‡∏Å‡∏•‡∏±‡∏ö‡∏°‡∏≤‡πÑ‡∏ó‡∏¢‡∏î‡πâ‡∏ß‡∏¢‡πÉ‡∏à‡∏°‡∏∏‡πà‡∏á‡∏°‡∏≤‡∏î‡∏õ‡∏£‡∏≤‡∏£‡∏ñ‡∏ô‡∏≤‡∏à‡∏∞‡∏û‡∏±‡∏í‡∏ô‡∏≤‡∏ö‡πâ‡∏≤‡∏ô‡πÄ‡∏Å‡∏¥‡∏î.‡∏ñ‡∏∂‡∏á‡∏Å‡∏£‡∏∞‡∏ô‡∏±‡πâ‡∏ô‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡∏Ç‡∏≠‡∏á‡∏ô‡∏±‡∏Å‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏Å‡πá‡∏¢‡∏±‡∏á‡πÄ‡∏ö‡∏≤‡πÄ‡∏™‡∏µ‡∏¢‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡πÄ‡∏Å‡∏¥‡∏ô‡πÄ‡∏ö‡∏≤‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏ô ‡∏ä‡∏ß‡∏ô‡πÉ‡∏´‡πâ‡∏™‡∏á‡∏™‡∏±‡∏¢‡∏ß‡πà‡∏≤‡∏ú‡∏π‡πâ‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏õ‡∏£‡∏∞‡πÄ‡∏ó‡∏®‡πÑ‡∏î‡πâ‡∏¢‡∏¥‡∏ô‡∏ö‡πâ‡∏≤‡∏á‡πÑ‡∏´‡∏°‡πÄ‡∏ö‡∏≤‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏ô ‡∏õ‡∏£‡∏∞‡πÄ‡∏ó‡∏®‡πÑ‡∏ó‡∏¢‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏à‡∏∞‡πÅ‡∏¢‡πà‡πÄ‡∏ö‡∏≤‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏ô ‡∏Ñ‡∏ô‡∏ó‡∏µ‡πà‡πÅ‡∏ö‡∏Å‡∏ó‡∏∏‡∏Å‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÑ‡∏ß‡πâ‡∏Ñ‡∏∑‡∏≠‡∏õ‡∏£‡∏∞‡∏ä‡∏≤‡∏ä‡∏ô‡πÄ‡∏ö‡∏≤‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏ô ‡∏ä‡∏ß‡∏ô‡πÉ‡∏´‡πâ‡∏™‡∏á‡∏™‡∏±‡∏¢‡∏ß‡πà‡∏≤‡∏Ñ‡∏ß‡∏£‡∏û‡∏¢‡∏≤‡∏¢‡∏≤‡∏°‡∏™‡πà‡∏á‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡∏ï‡πà‡∏≠‡πÑ‡∏õ‡πÑ‡∏´‡∏°]]></summary></entry><entry><title type="html">‡∏ô‡∏≤‡∏¨‡∏¥‡∏Å‡∏≤‡∏ß‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡∏ú‡∏±‡∏ô‡∏ï‡∏±‡∏ß‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏î‡∏π‡πÅ‡∏•‡∏™‡∏∏‡∏Ç‡∏†‡∏≤‡∏û</title><link href="https://kuchikinamthip.github.io/blog/2025/miss-asthma-th-blog-post.html/" rel="alternate" type="text/html" title="‡∏ô‡∏≤‡∏¨‡∏¥‡∏Å‡∏≤‡∏ß‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡∏ú‡∏±‡∏ô‡∏ï‡∏±‡∏ß‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏î‡∏π‡πÅ‡∏•‡∏™‡∏∏‡∏Ç‡∏†‡∏≤‡∏û"/><published>2025-09-16T09:21:00+00:00</published><updated>2025-09-16T09:21:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/miss-asthma-th-blog-post.html</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/miss-asthma-th-blog-post.html/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[‡∏ô‡∏≤‡∏¨‡∏¥‡∏Å‡∏≤‡∏ß‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡∏ú‡∏±‡∏ô‡∏ï‡∏±‡∏ß‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏î‡∏π‡πÅ‡∏•‡∏™‡∏∏‡∏Ç‡∏†‡∏≤‡∏û&nbsp;‡∏ö‡∏≤‡∏á‡∏ó‡∏µ‡∏ô‡∏≤‡∏¨‡∏¥‡∏Å‡∏≤‡∏Å‡πá‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏Ñ‡∏£‡∏∑‡πà‡∏≠‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡πÉ‡∏à‡∏ä‡∏±‡πâ‡∏ô‡∏î‡∏µ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà‡πÅ‡∏Ñ‡πà‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡πÄ‡∏ß‡∏•‡∏≤ ‡πÅ‡∏ï‡πà‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô heart rate ‡∏î‡πâ‡∏ß‡∏¢‡πÑ‡∏≠‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ó‡∏µ‡πà‡∏ä‡∏≠‡∏ö‡πÄ‡∏î‡∏¥‡∏ô‡πÄ‡∏£‡πá‡∏ß‡πÜ‡πÉ‡∏´‡πâ‡∏•‡∏°‡∏ï‡∏µ‡∏´‡∏ô‡πâ‡∏≤‡∏Å‡πá‡∏à‡∏∞‡πÑ‡∏°‡πà‡∏Ñ‡∏ß‡∏£‡∏ó‡∏≥‡πÉ‡∏ô‡∏ä‡πà‡∏ß‡∏á‡πÄ‡∏õ‡∏∑‡πà‡∏≠‡∏¢‡πÜ‡πÄ‡∏ó‡πà‡∏≤‡πÑ‡∏´‡∏£‡πà‡πÄ‡∏£‡∏≤‡∏à‡∏∞‡∏´‡∏•‡∏≠‡∏Å‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á‡∏î‡πâ‡∏ß‡∏¢‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡πá‡πÑ‡∏î‡πâ ‡πÅ‡∏ï‡πà heart rate(HR)‡∏à‡∏∞‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏ß‡∏±‡∏ô‡πÇ‡∏Å‡∏´‡∏Å‡∏Ñ‡∏∏‡∏ì‡πÄ‡∏Å‡∏∑‡∏≠‡∏ö 140 ‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡∏´‡∏±‡∏ß‡∏ß‡∏±‡∏ô‡∏Å‡∏±‡∏ô‡πÑ‡∏õ‡πÄ‡∏•‡∏¢.‡∏û‡∏±‡∏Å‡∏´‡∏•‡∏±‡∏á‡∏Å‡πá‡∏û‡∏¢‡∏≤‡∏¢‡∏≤‡∏°‡∏£‡∏π‡πâ‡∏à‡∏±‡∏Å‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á‡πÉ‡∏´‡πâ‡∏°‡∏≤‡∏Å‡∏Ç‡∏∂‡πâ‡∏ô‡∏°‡∏±‡∏ô‡∏Å‡πá‡πÑ‡∏°‡πà‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏á‡πà‡∏≤‡∏¢‡πÜ ‡∏à‡∏∞‡∏ñ‡∏≤‡∏°‡πÉ‡∏Ñ‡∏£‡∏Å‡πá‡∏Ñ‡∏á‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏î‡πâ‡∏ß‡∏¢‡∏ô‡∏¥‡∏™‡∏±‡∏¢‡∏ó‡∏µ‡πà‡∏ñ‡πâ‡∏≤‡∏à‡∏∞‡∏ó‡∏≥ ‡∏Å‡πá‡∏ï‡πâ‡∏≠‡∏á‡∏ó‡∏≥.‡∏°‡∏µ‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏ô‡∏≠‡∏ô ‡∏£‡∏û. ‡∏û‡∏≠‡∏¢‡∏≤‡∏â‡∏µ‡∏î ‡∏¢‡∏≤‡∏û‡πà‡∏ô‡∏≠‡∏≠‡∏Å‡∏§‡∏ó‡∏ò‡∏¥‡πå‡∏ö‡∏≠‡∏Å‡πÅ‡∏°‡πà‡∏ß‡πà‡∏≤‡∏û‡∏£‡∏∏‡πà‡∏á‡∏ô‡∏µ‡πâ‡∏Å‡∏•‡∏±‡∏ö‡∏ö‡πâ‡∏≤‡∏ô‡∏Å‡∏±‡∏ô‡∏û‡∏≠‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏§‡∏ó‡∏ò‡∏¥‡πå‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô‡∏´‡∏•‡πà‡∏∞ ‡∏ô‡∏≠‡∏ô‡∏´‡∏≠‡∏ö‡πÄ‡∏õ‡πá‡∏ô‡πÅ‡∏°‡∏ß‡πÄ‡∏•‡∏¢.‡πÄ‡∏Ñ‡∏¢‡∏Ñ‡∏¥‡∏î‡∏ß‡πà‡∏≤‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ó‡∏µ‡πà‡∏ß‡∏±‡∏î‡∏≠‡∏≠‡∏Å‡∏ã‡∏¥‡πÄ‡∏à‡∏ô‡∏õ‡∏•‡∏≤‡∏¢‡∏ô‡∏¥‡πâ‡∏ß‡πÅ‡∏ï‡πà‡∏Å‡πá‡∏°‡∏µ‡∏ö‡∏≤‡∏á‡πÄ‡∏´‡∏ï‡∏∏‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡∏ß‡πà‡∏≤HR ‡∏ô‡∏µ‡πà‡πÅ‡∏´‡∏•‡∏∞ ‡∏ô‡πà‡∏≤‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏Å‡∏ß‡πà‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡πÑ‡∏´‡∏ô‡πÜ.‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡∏°‡∏µ‡∏ô‡∏≤‡∏¨‡∏¥‡∏Å‡∏≤‡∏Å‡πá‡πÄ‡∏•‡∏¢‡∏ä‡πà‡∏ß‡∏¢‡πÑ‡∏î‡πâ‡πÄ‡∏¢‡∏≠‡∏∞ ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏≠‡∏≠‡∏Å‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏Å‡∏≤‡∏¢‡∏Å‡πá‡∏î‡πâ‡∏ß‡∏¢ ‡πÄ‡∏•‡∏¥‡∏Å‡∏ö‡πâ‡∏≤‡∏ß‡∏¥‡πà‡∏á‡πÉ‡∏´‡πâ‡πÄ‡∏£‡πá‡∏ß ‡∏õ‡∏±‡πà‡∏ô‡πÉ‡∏´‡πâ‡πÄ‡∏£‡πá‡∏ß ‡∏Ç‡∏≠‡πÄ‡∏£‡πá‡∏ß‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡∏µ‡∏Å‡∏ô‡∏¥‡∏î‡∏ô‡∏∂‡∏á‡∏™‡∏∏‡∏î‡∏ó‡πâ‡∏≤‡∏¢‡∏Å‡πá‡∏´‡∏≠‡∏ö‡∏Å‡∏≥‡πÄ‡∏£‡∏¥‡∏ö ‡∏ï‡∏≠‡∏ô‡∏ô‡∏µ‡πâ‡∏Å‡∏•‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡∏Ñ‡∏∏‡∏°‡πÇ‡∏ã‡∏ô ‡∏Å‡πá‡πÑ‡∏°‡πà‡∏ñ‡∏∂‡∏á‡∏Å‡∏±‡∏ö‡πÇ‡∏ã‡∏ô 2 ‡∏ï‡∏•‡∏≠‡∏î‡∏´‡∏£‡∏≠‡∏Å‡πÅ‡∏Ñ‡πà‡∏≠‡∏¢‡πà‡∏≤‡πÄ‡∏¢‡∏≠‡∏∞‡∏à‡∏ô‡πÇ‡∏ã‡∏ô 4 ‡∏õ‡∏•‡∏≤‡∏¢‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏≠‡∏≠‡∏Å‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏Å‡∏≤‡∏¢‡πÅ‡∏•‡πâ‡∏Å‡∏£‡∏∞‡∏ï‡∏∏‡πâ‡∏ô‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î‡∏Å‡πá‡πÑ‡∏°‡πà‡∏°‡∏µ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢.‡πÑ‡∏î‡πâ‡πÅ‡∏ï‡πà‡∏´‡∏ß‡∏±‡∏á‡∏ß‡πà‡∏≤ Garmin instinct ‡∏ó‡∏µ‡πà‡∏ã‡∏∑‡πâ‡∏≠‡∏°‡∏≤‡∏à‡∏∞‡πÑ‡∏î‡πâ‡πÉ‡∏ä‡πâ‡∏Å‡∏±‡∏ö‡∏Å‡∏µ‡∏¨‡∏≤‡∏™‡∏°‡∏ö‡∏∏‡∏Å‡∏™‡∏°‡∏ö‡∏±‡∏ô ‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ó‡∏µ‡πà‡∏°‡∏±‡∏ô‡∏Ñ‡∏ß‡∏£‡∏à‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏ö‡πâ‡∏≤‡∏á.‡∏ß‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡πÄ‡∏à‡∏≠‡∏´‡∏°‡∏≠‡∏ï‡∏≤‡∏°‡∏ô‡∏±‡∏î‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏Å‡∏±‡∏ö‡πÑ‡∏î‡πâ‡πÉ‡∏ö‡∏£‡∏±‡∏ö‡∏£‡∏≠‡∏á‡πÅ‡∏û‡∏ó‡∏¢‡πå‡∏ó‡∏µ‡πà‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡∏ß‡πà‡∏≤ ‚Äú‡πÇ‡∏£‡∏Ñ‡∏´‡∏∑‡∏î‡∏£‡∏∏‡∏ô‡πÅ‡∏£‡∏á‚Äù ‡πÅ‡∏•‡πâ‡∏ß‡∏Å‡πá‡πÄ‡∏ï‡∏¥‡∏° ‚Äú‡∏°‡∏≤‡∏Å‚Äù ‡πÑ‡∏ß‡πâ‡∏Ç‡πâ‡∏≤‡∏á‡∏´‡∏•‡∏±‡∏á‡∏≠‡∏µ‡∏Å‡∏ó‡∏µ‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡πÑ‡∏î‡πâ‡∏≠‡∏±‡∏û‡πÄ‡∏ß‡∏• 5555 ‡πÑ‡∏°‡πà‡∏£‡∏π‡πâ‡∏à‡∏∞‡∏î‡∏µ‡πÉ‡∏à‡∏´‡∏£‡∏∑‡∏≠‡πÄ‡∏™‡∏µ‡∏¢‡πÉ‡∏à‡∏î‡∏µ ‡∏ñ‡πâ‡∏≤‡∏Ñ‡∏≤‡∏î‡∏´‡∏ß‡∏±‡∏á‡∏Å‡∏±‡∏ö‡∏≠‡∏∞‡πÑ‡∏£‡πÜ‡πÉ‡∏´‡πâ‡∏ô‡πâ‡∏≠‡∏¢‡∏•‡∏á ‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏∏‡∏Ç‡∏°‡∏≤‡∏Å‡∏Ç‡∏∂‡πâ‡∏ô‡∏Å‡πá‡πÑ‡∏î‡πâ ‡πÅ‡∏°‡πâ‡∏ß‡πà‡∏≤‡∏à‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏à‡∏≠‡∏Å‡∏±‡∏ö‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡πá‡∏ï‡∏≤‡∏°.‡∏™‡∏±‡∏õ‡∏î‡∏≤‡∏´‡πå‡∏ô‡πà‡∏≤‡∏à‡∏∞‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏≠‡∏≠‡∏Å‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏Å‡∏≤‡∏¢‡πÑ‡∏î‡πâ‡∏ö‡πâ‡∏≤‡∏á‡πÅ‡∏•‡πâ‡∏ß‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏ô‡πâ‡∏≤‡∏ô‡∏µ‡πâ‡∏≠‡∏∏‡∏ï‡∏™‡πà‡∏≤‡∏´‡πå‡∏ï‡∏∑‡πà‡∏ô‡πÄ‡∏ä‡πâ‡∏≤‡πÑ‡∏õ‡∏ß‡∏¥‡πà‡∏á‡∏ó‡∏∏‡∏Å‡∏ß‡∏±‡∏ô‡∏ï‡∏±‡πâ‡∏á‡∏´‡∏•‡∏≤‡∏¢‡∏ß‡∏±‡∏ô ‡∏î‡∏±‡∏ô‡∏°‡∏≤‡πÅ‡∏û‡πâ‡πÄ‡∏¢‡∏≠‡∏∞‡∏ã‡∏∞‡πÑ‡∏î‡πâ ‡πÅ‡∏≠‡∏ö‡πÄ‡∏™‡∏µ‡∏¢‡∏î‡∏≤‡∏¢‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡∏Å‡∏±‡∏ô‡πÑ‡∏°‡πà‡πÄ‡∏õ‡πá‡∏ô‡πÑ‡∏£‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏ï‡πâ‡∏ô‡πÉ‡∏´‡∏°‡πà‡∏Å‡∏±‡∏ô‡∏≠‡∏µ‡∏Å‡∏£‡∏≠‡∏ö ‡∏ã‡∏∂‡πà‡∏á‡πÄ‡∏õ‡πá‡∏ô‡∏£‡∏≠‡∏ö‡∏ó‡∏µ‡πà‡πÄ‡∏ó‡πà‡∏≤‡πÑ‡∏´‡∏£‡πà‡∏Å‡πá‡πÑ‡∏°‡πà‡∏£‡∏π‡πâ #‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ‡∏ö‡πâ‡∏≤‡∏û‡∏•‡∏±‡∏á #SevereAsthma #Anaphylaxis#‡∏ó‡∏µ‡∏°‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡πà‡∏ô #‡∏ó‡∏µ‡∏°‡∏†‡∏π‡∏°‡∏¥‡∏ä‡∏ô‡∏∞‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠ 27 ‡∏™‡∏¥‡∏á‡∏´‡∏≤‡∏Ñ‡∏° 2020&nbsp; &nbsp;]]></summary></entry><entry><title type="html">‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏°‡∏±‡∏ô‡∏Å‡πá‡πÅ‡∏Ñ‡πà‚Ä¶‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏ô‡∏±‡πà‡∏ô‡πÅ‡∏´‡∏•‡∏∞</title><link href="https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_15.html/" rel="alternate" type="text/html" title="‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏°‡∏±‡∏ô‡∏Å‡πá‡πÅ‡∏Ñ‡πà‚Ä¶‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏ô‡∏±‡πà‡∏ô‡πÅ‡∏´‡∏•‡∏∞"/><published>2025-09-15T09:18:00+00:00</published><updated>2025-09-15T09:18:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_15.html</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/write-2-thrive-blog-post_15.html/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏°‡∏±‡∏ô‡∏Å‡πá‡πÅ‡∏Ñ‡πà...‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏ô‡∏±‡πà‡∏ô‡πÅ‡∏´‡∏•‡∏∞‚Äú‡πÄ‡∏à‡πÄ‡∏à‡πâ ‡∏ß‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡πÇ‡∏≠‡πÄ‡∏ä‡∏µ‡πà‡∏¢‡∏ô‡∏™‡∏≠‡∏ö‡∏ó‡∏µ‡πà‡πÇ‡∏£‡∏á‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏î‡πâ‡∏ß‡∏¢‚Äù‡πÄ‡∏™‡∏µ‡∏¢‡∏á‡πÄ‡∏î‡πá‡∏Å‡πÅ‡∏™‡∏ö‡∏£‡∏∞‡∏£‡∏∑‡πà‡∏ô‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏õ‡∏•‡∏≤‡∏¢‡∏™‡∏≤‡∏¢‡∏ó‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡∏¢‡∏±‡∏á‡πÑ‡∏°‡πà‡∏£‡∏π‡πâ‡πÄ‡∏•‡∏¢‡∏ß‡πà‡∏≤‡∏™‡∏≠‡∏ö‡∏ï‡∏Å‡∏´‡∏£‡∏∑‡∏≠‡∏™‡∏≠‡∏ö‡∏ú‡πà‡∏≤‡∏ô .‡∏à‡∏∞‡∏ß‡πà‡∏≤‡πÑ‡∏õ‡∏û‡∏≠‡πÇ‡∏ï‡∏°‡∏≤‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏°‡∏±‡∏ô‡∏Å‡πá‡πÅ‡∏Ñ‡πà‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö‡∏ô‡∏±‡πà‡∏ô‡πÅ‡∏´‡∏•‡∏∞‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà‡∏ß‡πà‡∏≤‡∏Å‡∏≤‡∏£‡∏ß‡∏±‡∏î‡∏ú‡∏•‡∏°‡∏±‡∏ô‡πÑ‡∏°‡πà‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πâ‡∏ö‡∏£‡∏£‡∏ó‡∏±‡∏î‡∏≠‡∏±‡∏ô‡πÄ‡∏î‡∏µ‡∏¢‡∏ß‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏ß‡∏±‡∏î‡∏ó‡∏±‡πâ‡∏á‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏Ñ‡∏á‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ.‡∏´‡∏•‡∏±‡∏á‡∏à‡∏≤‡∏Å‡πÇ‡∏ï‡∏°‡∏≤‡∏™‡∏±‡∏Å‡∏´‡∏ô‡πà‡∏≠‡∏¢‡∏Å‡πá‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡∏ß‡πà‡∏≤‡∏Å‡∏≤‡∏£‡∏™‡∏≠‡∏ö‡πÑ‡∏î‡πâ‡∏•‡∏≥‡∏î‡∏±‡∏ö‡∏ó‡∏µ‡πà‡∏î‡∏µ‡∏î‡∏µ‡πÉ‡∏ô‡∏ï‡∏≠‡∏ô‡∏õ‡∏£‡∏∞‡∏ñ‡∏°‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÅ‡∏õ‡∏•‡∏ß‡πà‡∏≤‡∏à‡∏∞‡∏õ‡∏£‡∏∞‡∏™‡∏ö‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡πÉ‡∏ô‡∏ä‡πà‡∏ß‡∏á‡∏°‡∏±‡∏ò‡∏¢‡∏°‡∏°‡∏´‡∏≤‡∏•‡∏±‡∏¢ ‡∏´‡∏£‡∏∑‡∏≠‡∏ä‡πà‡∏ß‡∏á‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏ú‡∏π‡πâ‡πÉ‡∏´‡∏ç‡πà‡πÄ‡∏ó‡πà‡∏≤‡πÑ‡∏´‡∏£‡πà‡∏ô‡∏±‡∏Å.‡πÉ‡∏ô‡∏ß‡∏±‡∏¢‡πÄ‡∏î‡πá‡∏Å‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏ô‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô...‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡πÄ‡∏Å‡πà‡∏á‡∏°‡∏≤‡∏Å‡∏Å‡∏Å ‡πÄ‡∏£‡∏µ‡∏¢‡∏ö‡∏£‡πâ‡∏≠‡∏¢‡∏°‡∏≤‡∏Å ‡∏•‡∏≤‡∏¢‡∏°‡∏∑‡∏≠‡∏™‡∏ß‡∏¢ ‡∏Ñ‡∏£‡∏π‡∏ä‡∏°‡∏ó‡∏∏‡∏Å‡∏ß‡∏±‡∏ô‡∏û‡∏≠‡πÄ‡∏Ç‡πâ‡∏≤‡∏ß‡∏±‡∏¢‡∏°‡∏±‡∏ò‡∏¢‡∏° ‡∏Å‡∏•‡∏±‡∏ö‡∏Å‡∏•‡∏≤‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡∏≠‡∏µ‡∏Å‡∏Ñ‡∏ô ‡πÅ‡∏ï‡πà‡∏á‡∏ï‡∏±‡∏ß‡∏à‡∏±‡∏î‡∏à‡πâ‡∏≤‡∏ô ‡πÉ‡∏ä‡πâ‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏Å‡πá‡πÅ‡∏¢‡πà‡∏•‡∏á‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏ô‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô...‡∏™‡∏≠‡∏ö‡πÄ‡∏Ç‡πâ‡∏≤‡∏°‡∏±‡∏ò‡∏¢‡∏°‡πÉ‡∏ô‡∏´‡πâ‡∏≠‡∏á‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏î‡∏µ‡∏ó‡∏µ‡πà‡∏™‡∏∏‡∏î ‡∏ä‡πà‡∏ß‡∏á‡∏´‡∏•‡∏±‡∏á‡πÄ‡∏Å‡∏Å‡∏°‡∏∞‡πÄ‡∏´‡∏£‡∏Å‡πÄ‡∏Å‡πÄ‡∏£ ‡πÅ‡∏•‡∏∞‡∏ï‡πâ‡∏≠‡∏á‡∏à‡∏ö‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏•‡∏á‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏Ñ‡∏ß‡∏≤‡∏°‡∏Ñ‡∏∂‡∏Å‡∏Ñ‡∏∞‡∏ô‡∏≠‡∏á‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏ô‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô...‡∏Ñ‡∏∂‡∏Å‡∏≠‡πà‡∏≤‡∏ô‡∏´‡∏ô‡∏±‡∏á‡∏™‡∏∑‡∏≠‡∏Ç‡∏∂‡πâ‡∏ô‡∏°‡∏≤‡∏Å‡πá‡πÑ‡∏î‡πâ‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏î‡∏µ ‡∏™‡∏≠‡∏ö‡∏≠‡∏∞‡πÑ‡∏£‡∏ó‡∏µ‡πà‡∏≠‡∏¢‡∏≤‡∏Å‡πÑ‡∏î‡πâ‡∏Å‡πá‡∏ú‡πà‡∏≤‡∏ô ‡πÅ‡∏ï‡πà‡∏´‡∏•‡∏±‡∏á‡∏à‡∏≤‡∏Å‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡πÑ‡∏î‡πâ‡∏Å‡πá‡∏ó‡∏∏‡∏•‡∏±‡∏Å‡∏ó‡∏∏‡πÄ‡∏• ‡∏à‡∏ô‡∏™‡∏∏‡∏î‡∏ó‡πâ‡∏≤‡∏¢‡∏Å‡πá‡πÑ‡∏°‡πà‡∏ñ‡∏∂‡∏á‡∏õ‡∏•‡∏≤‡∏¢‡∏ó‡∏≤‡∏á.‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏ô‡∏≠‡∏µ‡∏Å‡∏´‡∏•‡∏≤‡∏¢‡πÜ‡∏Ñ‡∏ô...‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏´‡∏ß‡∏∑‡∏≠‡∏´‡∏ß‡∏≤ ‡∏ö‡πâ‡∏≤‡∏á‡∏Å‡πá‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢‡πÜ ‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÇ‡∏î‡∏î‡πÄ‡∏î‡πà‡∏ô ‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏à‡∏ö ‡∏°‡∏µ‡∏á‡∏≤‡∏ô‡∏ó‡∏≥ ‡∏ö‡πâ‡∏≤‡∏á‡∏Å‡πá‡∏°‡∏µ‡∏Ñ‡∏£‡∏≠‡∏ö‡∏Ñ‡∏£‡∏±‡∏ß ‡∏Å‡πá‡∏Ñ‡∏á‡∏à‡∏∞‡∏ñ‡∏∑‡∏≠‡πÑ‡∏î‡πâ‡∏ß‡πà‡∏≤‡∏õ‡∏£‡∏∞‡∏™‡∏ö‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡πÉ‡∏ô‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ô‡πâ‡∏≠‡∏¢‡πÜ‡∏Å‡πá‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏ä‡πà‡∏ß‡∏á‡∏ß‡∏±‡∏¢‡∏ô‡∏µ‡πâ.‡∏™‡∏∏‡∏î‡∏ó‡πâ‡∏≤‡∏¢‡∏Å‡πá‡∏¢‡∏±‡∏á‡πÑ‡∏°‡πà‡∏£‡∏π‡πâ‡∏ß‡πà‡∏≤‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡∏ó‡∏µ‡πà‡∏ß‡πà‡∏≤‡∏°‡∏µ‡∏ï‡πâ‡∏ô‡πÄ‡∏´‡∏ï‡∏∏‡∏ï‡πâ‡∏ô‡∏ï‡∏≠‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏≠‡∏∞‡πÑ‡∏£‡∏™‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡∏Ñ‡∏£‡∏≠‡∏ö‡∏Ñ‡∏£‡∏±‡∏ß‡∏õ‡∏•‡∏π‡∏Å‡∏ù‡∏±‡∏á?‡∏ó‡∏±‡∏®‡∏ô‡∏Ñ‡∏ï‡∏¥? QE/IQ?.‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡∏°‡∏±‡∏ô‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏Ç‡∏∂‡πâ‡∏ô‡∏Å‡∏±‡∏ö‡∏ß‡πà‡∏≤‡∏™‡∏∏‡∏î‡∏ó‡πâ‡∏≤‡∏¢‡πÅ‡∏•‡πâ‡∏ß‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡πÅ‡∏ó‡πâ‡∏Ç‡∏≠‡∏á‡∏Ñ‡∏ô‡πÜ‡∏ô‡∏±‡πâ‡∏ô‡πÄ‡∏õ‡πá‡∏ô‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÑ‡∏£‡∏ñ‡πâ‡∏≤‡∏ï‡πâ‡∏≠‡∏á‡∏≠‡∏¢‡∏π‡πà‡∏î‡πâ‡∏ß‡∏¢‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á ‡∏ú‡∏•‡∏±‡∏Å‡∏î‡∏±‡∏ô‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á‡∏à‡∏∏‡∏î‡∏ô‡∏±‡πà‡∏ô‡∏Å‡∏£‡∏∞‡∏°‡∏±‡∏á ‡∏à‡∏∏‡∏î‡πÄ‡∏£‡∏¥‡πà‡∏°‡∏ï‡πâ‡∏ô‡∏Ç‡∏≠‡∏á‡∏ß‡∏±‡∏¢‡∏£‡∏∏‡πà‡∏ô‡∏ß‡∏±‡∏¢‡∏ó‡∏µ‡πà‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏≠‡∏∞‡πÑ‡∏£‡πÜ ‡∏î‡πâ‡∏ß‡∏¢‡∏ï‡∏±‡∏ß‡πÄ‡∏≠‡∏á.‡∏ö‡πâ‡∏≤‡∏á‡∏Å‡πá‡∏ß‡πà‡∏≤ GRIT ‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏â‡∏±‡∏ô‡∏ó‡∏∞ (Passion)+ ‡∏ß‡∏¥‡∏£‡∏¥‡∏¢‡∏∞ (Perserverance) ‡∏Ñ‡∏∑‡∏≠‡∏Å‡∏∏‡∏ç‡πÅ‡∏à‡∏Ç‡∏≠‡∏á‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à.‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏°‡∏µ‡∏≠‡∏∞‡πÑ‡∏£‡∏°‡∏≤‡∏Å‡∏°‡∏≤‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô‡∏Å‡πá‡πÄ‡∏õ‡πá‡∏ô‡πÑ‡∏î‡πâ‡πÅ‡∏ï‡πà‡∏ó‡∏µ‡πà‡πÅ‡∏ô‡πà‡πÜ‡∏Ñ‡∏∑‡∏≠‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏°‡∏µ‡πÅ‡∏Ñ‡πà‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏™‡∏≠‡∏ö&nbsp;‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠&nbsp;1 ‡∏Å‡∏±‡∏ô‡∏¢‡∏≤‡∏¢‡∏ô 2020&nbsp; &nbsp;]]></summary></entry><entry><title type="html">Demon Slayer: Hashira x Cancer-killing strategies</title><link href="https://kuchikinamthip.github.io/blog/2025/demon-slayer-hashira-x-cancer-killing-strategies/" rel="alternate" type="text/html" title="Demon Slayer: Hashira x Cancer-killing strategies"/><published>2025-09-14T10:29:00+00:00</published><updated>2025-09-14T10:29:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/demon-slayer-hashira-x-cancer-killing-strategies</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/demon-slayer-hashira-x-cancer-killing-strategies/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;&nbsp;üî• When the ‚ÄúHashira of Demon Slayer‚Äù face off against ‚ÄúCancer Demons‚Äù‚Ä¶ What real-world treatments do they represent? ‚ú® Hashira √ó Cancer-killing strategies üåä Giyu ‚Äì Water ‚Üí Chemotherapy üëâ Wide-flow attack across the battlefield, wiping out many enemies but sometimes hitting teammates too (side effects). üî• Rengoku ‚Äì Flame ‚Üí Radiotherapy üëâ Burns a precise target, breaking DNA apart ‚Äî best for ‚Äúpinpoint strikes.‚Äù ü¶ã Shinobu ‚Äì Insect ‚Üí Targeted Therapy / Monoclonal Antibody üëâ Sharp, needle-like poison aiming at ‚Äúmolecular weak points‚Äù (e.g., HER2, EGFR). Example: Trastuzumab (HERDARA) locks onto HER2 and blocks growth signals. üå´Ô∏è Tokito ‚Äì Mist ‚Üí Nanomedicine / Drug Delivery üëâ Tiny particles sneak through defenses, carrying drugs to unlock destruction at the target. üí•üé∂ Uzui ‚Äì Sound ‚Üí Surgery üëâ Timed, explosive precision ‚Äî removing the ‚Äúbig boss‚Äù tumor straight from the field. üêç Obanai ‚Äì Serpent ‚Üí Immunotherapy (Checkpoint Inhibitors / ADCC) üëâ Releases the immune system‚Äôs brakes so T-cells strike with venomous precision. üíó Mitsuri ‚Äì Love ‚Üí Endocrine Therapy (Hormone Therapy) üëâ Gentle but steady ‚Äî weakening the enemy by cutting off its hormonal fuel. ü™® Gyomei ‚Äì Stone ‚Üí Combination / Multimodal Therapy üëâ A fortress of strength, blending multiple powers: surgery + chemo + radiotherapy + targeted drugs. üå™Ô∏è Sanemi ‚Äì Wind ‚Üí Cellular Therapy (CAR-T / Adoptive T-cell) üëâ Frenzied reinforcements charging head-on, rewriting the rules of battle. Bonus warriors (not Hashira but deadly): üß¨ Antibody‚ÄìDrug Conjugates (ADC) = blades laced with hidden poison (e.g., T-DM1) üéØ Radioligand / PRRT=radioactive arrows hitting bullseyesüå± Anti-angiogenesis = cutting off the enemy‚Äôs blood supply‚ú® Science meets anime ‚Äî making oncology easier (and cooler) to learn. =============== Build a greater science together with me! Here is my blogsüå∏ Thai language: NO CANCER FB page/Blogger (https://lnkd.in/gQa3apBc or https://lnkd.in/gTqDK8MA)üß¨ English language: The Whispers of Biology (LinkedIn/Blogger) (https://lnkd.in/gRTnrpRz or https://lnkd.in/gRe_VtUF) #CancerEducation #Oncology #TargetedTherapy #Immunotherapy #HER2 #Trastuzumab #HERDARA #DemonSlayer #ScienceCommunication #NoCancerThailand]]></summary></entry><entry><title type="html">‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Ç‡∏≠‡∏á‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á (Reference)</title><link href="https://kuchikinamthip.github.io/blog/2025/reference/" rel="alternate" type="text/html" title="‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Ç‡∏≠‡∏á‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á (Reference)"/><published>2025-09-14T09:36:00+00:00</published><updated>2025-09-14T09:36:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/-reference</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/reference/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Ç‡∏≠‡∏á‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á (Reference)...‡∏ó‡∏µ‡πà‡∏à‡∏£‡∏¥‡∏á‡∏°‡∏µ‡πÄ‡∏´‡πá‡∏ô‡∏Å‡∏≤‡∏£‡∏´‡∏ô‡∏∂‡πà‡∏á‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏™‡∏∞‡∏î‡∏∏‡∏î‡∏Å‡∏±‡∏ö‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Ç‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏ñ‡∏∂‡∏á‡∏á‡∏≤‡∏ô‡∏ï‡πâ‡∏ô‡∏â‡∏ö‡∏±‡∏ö‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏°‡∏≤‡∏Å‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ô‡∏∂‡∏á‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô‡∏¢‡∏±‡∏á‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏°.5 ‡πÄ‡πÄ‡∏•‡∏∞‡πÑ‡∏õ‡πÄ‡∏Ç‡πâ‡∏≤‡∏Ñ‡πà‡∏≤‡∏¢ThaiSciCamp2 ‡∏Å‡∏≤‡∏£‡∏û‡∏π‡∏î‡∏Ç‡∏≠‡∏á‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡∏¢‡∏≠‡∏î‡∏´‡∏ó‡∏±‡∏¢ ‡πÄ‡∏ó‡∏û‡∏ò‡∏£‡∏≤‡∏ô‡∏ô‡∏ó‡πå‡∏ã‡∏∂‡πà‡∏á‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡∏û‡∏π‡∏î‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ß‡πà‡∏≤ [‡∏ú‡∏°‡πÄ‡∏õ‡πá‡∏ô‡∏Ñ‡∏ì‡∏∞‡∏Å‡∏£‡∏£‡∏Å‡∏≤‡∏£‡∏û‡∏¥‡∏à‡∏≤‡∏£‡∏ì‡∏≤‡πÄ‡∏î‡πá‡∏Å‡∏£‡∏±‡∏ö‡∏ó‡∏∏‡∏ô‡πÑ‡∏õ‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏ï‡πà‡∏≠ ‡∏õ.‡πÄ‡∏≠‡∏Å ‡πÅ‡∏ï‡πà‡∏ñ‡πâ‡∏≤‡πÄ‡∏Ñ‡πâ‡∏≤‡πÄ‡∏≠‡∏≤‡∏†‡∏≤‡∏û‡∏´‡∏£‡∏∑‡∏≠‡∏≠‡∏∞‡πÑ‡∏£‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡∏ó‡∏≥‡∏Ç‡∏∂‡πâ‡∏ô‡∏°‡∏≤‡πÄ‡∏≠‡∏á‡πÅ‡∏•‡πâ‡∏ß‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÉ‡∏´‡πâ‡πÄ‡∏Ñ‡∏£‡∏î‡∏¥‡∏ï‡πÄ‡∏à‡πâ‡∏≤‡∏Ç‡∏≠‡∏á‡∏á‡∏≤‡∏ô‡∏ú‡∏°‡∏à‡∏∞‡πÑ‡∏°‡πà‡πÉ‡∏´‡πâ‡∏Ñ‡∏ô‡∏û‡∏ß‡∏Å‡∏ô‡∏µ‡πâ‡πÑ‡∏õ‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏ï‡πà‡∏≠] ‡∏ß‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡∏Ñ‡∏∑‡∏≠‡πÄ‡∏á‡∏¥‡∏ö‡∏™‡∏á‡∏±‡∏î‡∏ó‡∏±‡πâ‡∏á‡∏ô‡∏±‡∏Å‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏¢‡∏≤‡∏ß‡πÑ‡∏õ‡∏ñ‡∏∂‡∏á‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏Å‡∏£‡∏ó‡πà‡∏≤‡∏ô‡∏≠‡∏∑‡πà‡∏ô‡πÉ‡∏ô‡∏ß‡∏±‡∏ô‡∏ô‡∏±‡πâ‡∏ô‚Äã ‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡∏ô‡∏±‡πâ‡∏ô‡∏°‡∏≤‡∏Å‡πá‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡∏ß‡πà‡∏≤‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç 5555+...‡∏ñ‡πâ‡∏≤‡∏à‡∏∞‡πÉ‡∏´‡πâ‡∏Ñ‡∏¥‡∏î‡πÄ‡∏•‡πà‡∏ô‡πÜ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Ç‡∏≠‡∏á‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏°‡∏µ‡πÄ‡∏¢‡∏≠‡∏∞‡∏°‡∏≤‡∏Å‡∏ô‡∏∞ ‡∏•‡∏¥‡∏™‡∏ï‡πå‡πÄ‡∏õ‡πá‡∏ô‡∏Ç‡πâ‡∏≠‡∏ô‡πà‡∏≤‡∏à‡∏∞‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ô‡∏µ‡πâ1. ‡πÄ‡∏õ‡πá‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏Ñ‡∏≤‡∏£‡∏û‡∏Ñ‡∏ß‡∏≤‡∏°‡∏Ñ‡∏¥‡∏î‡πÄ‡πÄ‡∏•‡∏∞‡∏ú‡∏•‡∏á‡∏≤‡∏ô‡∏Ç‡∏≠‡∏á‡∏ú‡∏π‡πâ‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏°‡∏≤ ‡∏ñ‡πâ‡∏≤‡πÑ‡∏°‡πà‡πÉ‡∏™‡πà‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏Ñ‡∏ô‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏Ñ‡∏¥‡∏î‡∏ß‡πà‡∏≤‡πÄ‡∏£‡∏≤‡∏Ñ‡∏¥‡∏î‡∏°‡∏±‡∏ô‡∏Ç‡∏∂‡πâ‡∏ô‡∏°‡∏≤‡πÑ‡∏î‡πâ‡πÄ‡∏≠‡∏á ‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏ô‡∏µ‡πà‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà‡πÅ‡∏Ñ‡πà‡πÄ‡∏õ‡πÄ‡∏õ‡∏≠‡∏£‡πå‡∏ó‡∏µ‡πà‡∏ô‡πà‡∏≤‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏ñ‡∏∑‡∏≠‡∏ô‡∏∞‡∏°‡∏±‡∏ô‡∏£‡∏ß‡∏°‡πÑ‡∏õ‡∏ñ‡∏∂‡∏á‡∏Ñ‡∏≥‡∏û‡∏π‡∏î‡πÅ‡∏•‡∏∞‡πÑ‡∏≠‡πÄ‡∏î‡∏µ‡∏¢‡∏î‡πâ‡∏ß‡∏¢2.‡πÄ‡∏õ‡πá‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ô‡πà‡∏≤‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏ñ‡∏∑‡∏≠‡πÉ‡∏´‡πâ‡∏á‡∏≤‡∏ô‡πÄ‡∏£‡∏≤ ‡∏≠‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡∏Ñ‡∏∑‡∏≠‡∏Å‡∏≤‡∏£‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏´‡∏£‡∏∑‡∏≠‡∏´‡∏ô‡∏±‡∏á‡∏™‡∏∑‡∏≠‡πÄ‡∏õ‡πá‡∏ô‡∏™‡πà‡∏ß‡∏ô‡πÉ‡∏´‡∏ç‡πà3. ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏£‡∏≤‡∏ï‡∏≤‡∏°‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Ç‡∏≠‡∏á‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡∏ô‡∏±‡πâ‡∏ô‡πÜ‡πÑ‡∏î‡πâ ‡∏≠‡∏±‡∏ô‡πÅ‡∏¢‡∏Å‡∏≠‡∏≠‡∏Å‡πÄ‡∏õ‡πá‡∏ô 2 ‡∏õ‡∏£‡∏∞‡πÄ‡∏î‡πá‡∏ô‡∏Ñ‡∏∑‡∏≠- ‡∏ï‡∏≤‡∏°‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡πÉ‡∏ô‡∏™‡πà‡∏ß‡∏ô‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢ ‡πÄ‡∏û‡∏∑‡πà‡∏≠‡πÑ‡∏õ‡∏´‡∏≤‡∏£‡∏≤‡∏¢‡∏•‡∏∞‡πÄ‡∏≠‡∏µ‡∏¢‡∏î‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Å‡∏Ç‡∏∂‡πâ‡∏ô‡∏à‡∏≤‡∏Å‡∏á‡∏≤‡∏ô‡∏ï‡πâ‡∏ô‡∏â‡∏ö‡∏±‡∏ö - ‡∏ï‡∏≤‡∏°‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡∏´‡∏•‡∏±‡∏á‡πÄ‡∏£‡∏µ‡∏¢‡∏ô ‡∏õ‡∏£‡∏∞‡πÄ‡∏î‡πá‡∏ô‡∏Å‡πá‡∏Ñ‡∏∑‡∏≠‡∏ó‡∏∏‡∏Å‡∏Ñ‡∏á‡πÄ‡∏Ñ‡∏¢‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï‡∏ß‡πà‡∏≤‡∏´‡∏•‡∏±‡∏á‡∏™‡πÑ‡∏•‡∏î‡πå‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡∏à‡∏∞‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏ó‡∏µ‡πà‡πÉ‡∏ä‡πâ‡∏õ‡∏£‡∏∞‡∏Å‡∏≠‡∏ö‡∏Å‡∏≤‡∏£‡∏™‡∏≠‡∏ô‡πÑ‡∏ß‡πâ‡πÅ‡∏ï‡πà‡∏Ñ‡∏á‡∏°‡∏µ‡∏ô‡πâ‡∏≠‡∏¢‡∏Ñ‡∏ô‡∏°‡∏≤‡∏Å‡∏ó‡∏µ‡πà‡∏à‡∏∞‡∏°‡∏≠‡∏á‡∏°‡∏±‡∏ô‡∏ó‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡∏à‡∏£‡∏¥‡∏á‡πÅ‡∏•‡πâ‡∏ß‡πÄ‡∏£‡∏≤‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡∏ß‡πà‡∏≤‡∏™‡πÑ‡∏•‡∏î‡πå‡∏ô‡∏µ‡πâ‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏°‡∏≤‡∏Å‡∏û‡∏≠‡πÜ‡∏Å‡∏±‡∏ö‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°(‡∏™‡∏≤‡∏£‡∏ö‡∏±‡∏ç)‡∏Ç‡∏≠‡∏á‡∏´‡∏±‡∏ß‡∏Ç‡πâ‡∏≠‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡πÅ‡∏•‡∏∞‡∏£‡∏π‡πâ‡∏™‡∏∂‡∏Å‡∏ß‡πà‡∏≤‡∏°‡∏±‡∏ô‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏Å‡∏ß‡πà‡∏≤‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡∏ã‡∏∞‡∏≠‡∏µ‡∏Å(‡πÉ‡∏ô‡∏ï‡∏≠‡∏ô‡∏ó‡∏µ‡πà‡∏™‡∏≠‡∏ö‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏ô‡∏±‡πâ‡∏ô‡πÑ‡∏õ‡πÅ‡∏•‡πâ‡∏ß‡∏≠‡πà‡∏∞‡∏ô‡∏∞555)‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏™‡πÑ‡∏•‡∏î‡πå‡∏ó‡∏µ‡πà‡∏ö‡∏≠‡∏Å‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°‡∏à‡∏∞‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏£‡∏≤‡πÄ‡∏´‡πá‡∏ô‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°‡∏ß‡πà‡∏≤‡∏°‡∏µ‡∏≠‡∏∞‡πÑ‡∏£‡∏ö‡πâ‡∏≤‡∏á‡∏ï‡∏£‡∏á‡πÑ‡∏´‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡πÇ‡∏ü‡∏Å‡∏±‡∏™‡∏™‡πà‡∏ß‡∏ô‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏à‡∏∞‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏£‡∏≤‡∏ï‡∏≤‡∏°‡πÑ‡∏õ‡∏´‡∏≤‡πÄ‡∏ô‡∏∑‡πâ‡∏≠‡∏´‡∏≤‡∏ó‡∏µ‡πà‡∏ô‡∏±‡∏ö‡∏ß‡∏±‡∏ô‡∏°‡∏±‡∏ô‡∏à‡∏∞update‡πÉ‡∏´‡∏°‡πà‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏¢‡πÜ‡πÅ‡∏•‡∏∞‡∏ó‡∏µ‡πà‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏ñ‡πâ‡∏≤‡πÄ‡∏£‡∏≤‡∏£‡∏π‡πâ‡∏ß‡πà‡∏≤‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡πÄ‡∏≠‡∏≤‡∏´‡∏±‡∏ß‡∏Ç‡πâ‡∏≠‡∏ô‡∏µ‡πâ‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡πÑ‡∏´‡∏ô‡πÉ‡∏ô‡∏ß‡∏±‡∏ô‡πÉ‡∏î‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡∏≠‡∏¢‡∏≤‡∏Å‡∏Å‡∏•‡∏±‡∏ö‡πÑ‡∏õ‡∏Å‡πá‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏ó‡∏≥‡πÑ‡∏î‡πâ..‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡πÄ‡∏≠‡∏≤‡πÄ‡∏Ç‡πâ‡∏≤‡∏à‡∏£‡∏¥‡∏á‡πÜ‡πÑ‡∏°‡πà‡∏°‡∏µ‡πÉ‡∏Ñ‡∏£‡πÅ‡∏ö‡∏Å‡∏ä‡∏µ‡∏ó‡πÄ‡∏£‡∏µ‡∏¢‡∏ô‡πÑ‡∏õ‡∏ï‡∏•‡∏≠‡∏î‡∏ä‡∏µ‡∏ß‡∏¥‡∏ï‡πÅ‡∏Ñ‡πà‡∏ô‡πâ‡∏≥‡∏ó‡πà‡∏ß‡∏°‡∏õ‡∏•‡∏ß‡∏Å‡∏Å‡∏¥‡∏ô‡∏Å‡πá‡πÄ‡∏Å‡∏•‡∏µ‡πâ‡∏¢‡∏á‡πÅ‡∏•‡πâ‡∏ß...‡∏Å‡∏≤‡∏£‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏ó‡∏µ‡πà‡∏°‡∏µ‡∏´‡∏•‡∏≤‡∏¢‡πÅ‡∏ö‡∏ö‡∏ó‡∏µ‡πà‡∏à‡∏£‡∏¥‡∏á‡∏Å‡πá‡∏Ñ‡∏á‡πÅ‡∏Ñ‡πà‡∏≠‡∏¢‡∏≤‡∏Å‡πÉ‡∏´‡πâ‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏ó‡∏µ‡πà‡∏à‡∏∞‡∏™‡∏∑‡∏ö‡∏Å‡∏•‡∏±‡∏ö‡πÑ‡∏õ‡πÑ‡∏î‡πâ‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á‡πÅ‡∏•‡∏∞‡∏Ñ‡∏£‡∏ö‡∏ñ‡πâ‡∏ß‡∏ô‡∏ô‡∏∞(‡∏Ñ‡∏¥‡∏î‡πÄ‡∏≠‡∏á555)....‡πÄ‡∏£‡∏≤‡πÄ‡∏≠‡∏á‡∏Å‡πá‡πÄ‡∏Ñ‡∏¢‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏Ç‡∏∂‡πâ‡∏ô‡∏™‡πÑ‡∏•‡∏î‡πå‡πÄ‡∏ä‡πà‡∏ô credit by ‡∏Å‡∏•‡∏∏‡πà‡∏°‡∏†‡∏≤‡∏©‡∏≤‡∏û‡∏≤‡∏ã‡∏ô ‡∏Å‡πá‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô‡∏ä‡∏∑‡πà‡∏≠‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡∏¥‡∏î‡πÑ‡∏°‡πà‡∏≠‡∏≠‡∏Å‡πÄ‡∏•‡∏¢‡∏Ç‡∏≠‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏´‡πá‡∏ô‡πÉ‡∏ô‡∏Å‡∏•‡∏∏‡πà‡∏°‡πÅ‡∏•‡∏∞‡πÑ‡∏î‡πâ‡πÄ‡∏≠‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏°‡∏≤‡πÉ‡∏ä‡πâ‡∏à‡∏£‡∏¥‡∏á‡∏Å‡∏±‡∏ö‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ôcredit by FB ‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡πÉ‡∏ô‡∏Ñ‡∏ì‡∏∞‡∏ó‡πà‡∏≤‡∏ô‡∏ô‡∏∂‡∏á‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô‡∏Å‡πá‡πÄ‡∏≠‡∏≤‡πÑ‡∏≠‡πÄ‡∏î‡∏µ‡∏¢‡∏ó‡∏µ‡πà‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡πÇ‡∏û‡∏™‡πÑ‡∏ß‡πâ‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏Å‡∏±‡∏ö‡∏Ñ‡∏ô‡πÑ‡∏Ç‡πâ‡πÅ‡∏•‡πâ‡∏ß‡∏ï‡πâ‡∏≠‡∏á‡∏Ç‡∏∂‡πâ‡∏ô‡∏™‡πÑ‡∏•‡∏î‡πå‡∏û‡∏£‡∏µ‡πÄ‡∏ã‡∏ô‡∏Å‡πá‡πÄ‡∏•‡∏¢‡∏Ç‡∏≠‡∏ö‡∏Ñ‡∏∏‡∏ì‡∏≠‡∏≤‡∏à‡∏≤‡∏£‡∏¢‡πå‡πÑ‡∏ß‡πâ‡∏ñ‡πâ‡∏≤‡πÑ‡∏°‡πà‡πÉ‡∏™‡πà‡πÄ‡∏î‡∏µ‡πã‡∏¢‡∏ß‡∏Ñ‡∏ô‡∏≠‡∏∑‡πà‡∏ô‡∏à‡∏∞‡πÄ‡∏Ç‡πâ‡∏≤‡πÉ‡∏à‡∏ß‡πà‡∏≤‡∏Ñ‡∏¥‡∏î‡πÑ‡∏î‡πâ‡πÄ‡∏≠‡∏á‡∏ô‡∏±‡πà‡∏ô‡∏à‡∏∞‡πÄ‡∏Å‡πà‡∏á‡πÄ‡∏Å‡∏¥‡∏ô‡πÑ‡∏õ5555...‡∏ó‡πà‡∏≤‡∏ô‡πÑ‡∏´‡∏ô‡∏°‡∏≤‡∏≠‡πà‡∏≤‡∏ô‡πÄ‡∏à‡∏≠‡πÇ‡∏û‡∏™‡∏ô‡∏µ‡πâ‡∏≠‡∏¢‡∏≤‡∏Å‡πÄ‡∏™‡∏ô‡∏≠‡∏≠‡∏∞‡πÑ‡∏£‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Å‡πá‡∏¢‡∏¥‡∏ô‡∏î‡∏µ‡πÄ‡∏•‡∏¢‡∏ô‡∏∞‡∏Ñ‡∏∞^^&nbsp;‡πÄ‡∏Ç‡∏µ‡∏¢‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠ 14 ‡∏Å‡∏±‡∏ô‡∏¢‡∏≤‡∏¢‡∏ô 2016&nbsp;&nbsp;]]></summary></entry><entry><title type="html">üß¨ ‡∏ó‡∏≥‡πÑ‡∏° #‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤ üéØ ‡∏ñ‡∏∂‡∏á‡∏ä‡∏≠‡∏ö‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ ‚Äú‡πÅ‡∏°‡∏ö‡πÜ‚Äù (Mab) ‡πÄ‡∏û‡∏¥‡πà‡∏á‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÅ‡∏°‡∏ö‡πÜ‡πÄ‡∏•‡∏¢‡∏ï‡∏±‡πâ‡∏á‡∏á‡∏µ‡πâ‡πÄ‡∏´‡∏£‡∏≠</title><link href="https://kuchikinamthip.github.io/blog/2025/mab/" rel="alternate" type="text/html" title="üß¨ ‡∏ó‡∏≥‡πÑ‡∏° #‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤ üéØ ‡∏ñ‡∏∂‡∏á‡∏ä‡∏≠‡∏ö‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ ‚Äú‡πÅ‡∏°‡∏ö‡πÜ‚Äù (Mab) ‡πÄ‡∏û‡∏¥‡πà‡∏á‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÅ‡∏°‡∏ö‡πÜ‡πÄ‡∏•‡∏¢‡∏ï‡∏±‡πâ‡∏á‡∏á‡∏µ‡πâ‡πÄ‡∏´‡∏£‡∏≠"/><published>2025-09-14T09:26:00+00:00</published><updated>2025-09-14T09:26:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/------mab-</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/mab/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;üßê ‡πÑ‡∏Ç‡∏Ç‡πâ‡∏≠‡∏™‡∏á‡∏™‡∏±‡∏¢! ‡∏ó‡∏≥‡πÑ‡∏° #‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤ ‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î ‡∏ñ‡∏∂‡∏á‡∏ä‡∏≠‡∏ö‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ "‡πÅ‡∏°‡∏ö‡πÜ" (Mab) ‡∏Å‡∏±‡∏ô‡∏ô‡∏∞? ü§®‡∏ó‡∏∏‡∏Å‡∏Ñ‡∏ô‡∏ô‡∏ô‡∏ô‡∏ô! üëã ‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡∏Ñ‡∏∏‡∏¢‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á "‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤" ‡∏Å‡∏±‡∏ô‡∏°‡∏≤‡πÄ‡∏ô‡∏µ‡πà‡∏¢ ‡∏°‡∏µ‡πÉ‡∏Ñ‡∏£‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï‡πÑ‡∏´‡∏°‡∏Ñ‡∏∞‡∏ß‡πà‡∏≤... ‡∏ó‡∏≥‡πÑ‡∏°‡∏ä‡∏∑‡πà‡∏≠‡∏¢‡∏≤‡∏û‡∏ß‡∏Å‡∏ô‡∏µ‡πâ‡∏ñ‡∏∂‡∏á‡∏ä‡∏≠‡∏ö‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ "‡πÅ‡∏°‡∏ö‡πÜ" (Mab) ‡∏Å‡∏±‡∏ô‡πÄ‡∏Å‡∏∑‡∏≠‡∏ö‡∏´‡∏°‡∏î‡πÄ‡∏•‡∏¢‡∏ô‡∏∞? ü§î‡∏°‡∏¥‡∏™‡πÑ‡∏õ‡πÄ‡∏à‡∏≠‡∏ö‡∏ó‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ß‡∏¥‡∏ä‡∏≤‡∏Å‡∏≤‡∏£‡∏≠‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡∏°‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏´‡∏±‡∏ß‡∏Ç‡πâ‡∏≠‡∏à‡πä‡∏≤‡∏ö‡∏°‡∏≤‡∏Å "Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab." ‡πÄ‡∏•‡∏¢‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Ç‡∏≠‡∏á‡πÇ‡∏û‡∏™‡∏ô‡∏µ‡πâ ‡∏à‡∏∞‡∏™‡∏±‡∏á‡πÄ‡∏Å‡∏ï‡∏ß‡πà‡∏≤‡∏¢‡∏≤‡∏ó‡∏∏‡∏Å‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢‡πÅ‡∏°‡∏ö‡∏´‡∏°‡∏î‡πÄ‡∏•‡∏¢‡∏ö‡∏≤‡∏á‡∏Ñ‡∏ô‡πÅ‡∏≠‡∏ö‡∏Ñ‡∏¥‡∏î‡πÉ‡∏ô‡πÉ‡∏à‡∏£‡∏∂‡πÄ‡∏õ‡∏•‡πà‡∏≤‡∏Ñ‡∏∞‡∏ß‡πà‡∏≤... "‡∏´‡∏£‡∏∑‡∏≠‡∏ß‡πà‡∏≤‡πÄ‡∏û‡∏¥‡πà‡∏á‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö (‡πÅ‡∏°‡∏ö‡πÜ) ‡πÄ‡∏•‡∏¢‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢‡πÅ‡∏°‡∏ö?" ü§£‡∏ß‡∏±‡∏ô‡∏ô‡∏µ‡πâ‡∏°‡∏¥‡∏™‡∏à‡∏∞‡∏°‡∏≤‡πÑ‡∏Ç‡∏Ç‡πâ‡∏≠‡∏Ç‡πâ‡∏≠‡∏á‡πÉ‡∏à‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏à‡πà‡∏≤‡∏á‡πÄ‡∏•‡∏¢‡∏Ñ‡πà‡∏∞! ‡∏ô‡∏µ‡πà‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏ö‡∏±‡∏á‡πÄ‡∏≠‡∏¥‡∏ç‡∏ô‡∏∞ ‡πÅ‡∏ï‡πà‡∏°‡∏±‡∏ô‡∏°‡∏µ‡πÄ‡∏´‡∏ï‡∏∏‡∏ú‡∏•‡∏ó‡∏≤‡∏á‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏ã‡πà‡∏≠‡∏ô‡∏≠‡∏¢‡∏π‡πà‡πÄ‡∏ö‡∏∑‡πâ‡∏≠‡∏á‡∏´‡∏•‡∏±‡∏á! ü§©üß¨ ‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤‡∏ó‡∏µ‡πà‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ "‡πÅ‡∏°‡∏ö‡πÜ" (Mab) ‡∏Ñ‡∏∑‡∏≠‡∏≠‡∏∞‡πÑ‡∏£? üéØ‚ú®‡πÄ‡∏â‡∏•‡∏¢‡πÄ‡∏•‡∏¢‡∏Ñ‡πà‡∏∞! ‡∏Ñ‡∏≥‡∏ß‡πà‡∏≤ "‡πÅ‡∏°‡∏ö" (Mab) ‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡πÄ‡∏´‡πá‡∏ô‡∏≠‡∏¢‡∏π‡πà‡∏ó‡πâ‡∏≤‡∏¢‡∏ä‡∏∑‡πà‡∏≠‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤‡πÄ‡∏´‡∏•‡πà‡∏≤‡∏ô‡∏µ‡πâ ‡∏¢‡πà‡∏≠‡∏°‡∏≤‡∏à‡∏≤‡∏Å‡∏Ñ‡∏≥‡∏ß‡πà‡∏≤ "Monoclonal Antibody" (‡πÇ‡∏°‡πÇ‡∏ô‡πÇ‡∏Ñ‡∏•‡∏ô‡∏≠‡∏• ‡πÅ‡∏≠‡∏ô‡∏ï‡∏¥‡∏ö‡∏≠‡∏î‡∏µ) ‡∏ô‡∏±‡πà‡∏ô‡πÄ‡∏≠‡∏á‡∏Ñ‡πà‡∏∞! ‚ú®üß¨‡πÅ‡∏•‡πâ‡∏ß Monoclonal Antibody ‡∏Ñ‡∏∑‡∏≠‡∏≠‡∏∞‡πÑ‡∏£?‚ú®&nbsp;‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢‡∏á‡πà‡∏≤‡∏¢‡πÜ ‡∏ô‡∏∞‡∏Ñ‡∏∞ ‡∏°‡∏±‡∏ô‡∏Å‡πá‡∏Ñ‡∏∑‡∏≠ "‡πÅ‡∏≠‡∏ô‡∏ï‡∏¥‡∏ö‡∏≠‡∏î‡∏µ‡∏™‡∏±‡∏á‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå" ‡∏´‡∏£‡∏∑‡∏≠ "‡πÇ‡∏õ‡∏£‡∏ï‡∏µ‡∏ô‡∏†‡∏π‡∏°‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Å‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ñ‡∏π‡∏Å‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏Ç‡∏∂‡πâ‡∏ô‡πÉ‡∏ô‡∏´‡πâ‡∏≠‡∏á‡∏õ‡∏è‡∏¥‡∏ö‡∏±‡∏ï‡∏¥‡∏Å‡∏≤‡∏£" ‡∏Ñ‡πà‡∏∞! üë©‚Äçüî¨‚ú®&nbsp;‡∏•‡∏≠‡∏á‡∏ô‡∏∂‡∏Å‡∏†‡∏≤‡∏û‡∏ß‡πà‡∏≤‡πÉ‡∏ô‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡πÄ‡∏£‡∏≤‡∏°‡∏µ‡∏ï‡∏≥‡∏£‡∏ß‡∏à (‡πÅ‡∏≠‡∏ô‡∏ï‡∏¥‡∏ö‡∏≠‡∏î‡∏µ) ‡∏ó‡∏µ‡πà‡∏Ñ‡∏≠‡∏¢‡∏à‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏£‡πâ‡∏≤‡∏¢ (‡∏™‡∏≤‡∏£‡∏ú‡∏¥‡∏î‡∏õ‡∏Å‡∏ï‡∏¥) ‡πÉ‡∏ä‡πà‡πÑ‡∏´‡∏°‡∏Ñ‡∏∞? ‡πÅ‡∏≠‡∏ô‡∏ï‡∏¥‡∏ö‡∏≠‡∏î‡∏µ‡∏õ‡∏Å‡∏ï‡∏¥‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡∏à‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏£‡πâ‡∏≤‡∏¢‡πÑ‡∏î‡πâ‡∏´‡∏•‡∏≤‡∏¢‡∏Ñ‡∏ô ‡πÅ‡∏ï‡πà "Monoclonal Antibody" ‡πÄ‡∏ô‡∏µ‡πà‡∏¢ ‡∏Ñ‡∏∑‡∏≠‡∏ï‡∏≥‡∏£‡∏ß‡∏à‡∏û‡∏¥‡πÄ‡∏®‡∏©‡∏ó‡∏µ‡πà‡∏ñ‡∏π‡∏Å‡∏ù‡∏∂‡∏Å‡∏°‡∏≤‡πÉ‡∏´‡πâ‡∏à‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏£‡πâ‡∏≤‡∏¢ "‡πÅ‡∏Ñ‡πà‡∏Ñ‡∏ô‡πÄ‡∏î‡∏µ‡∏¢‡∏ß" ‡∏ó‡∏µ‡πà‡∏°‡∏µ‡∏•‡∏±‡∏Å‡∏©‡∏ì‡∏∞‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡πÄ‡∏à‡∏≤‡∏∞‡∏à‡∏á‡∏°‡∏≤‡∏Å‡πÜ ‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô‡∏Ñ‡πà‡∏∞!üéØ&nbsp;‡∏ô‡∏µ‡πà‡πÅ‡∏´‡∏•‡∏∞‡∏Ñ‡∏∑‡∏≠‡∏´‡∏±‡∏ß‡πÉ‡∏à‡∏Ç‡∏≠‡∏á "‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡πÅ‡∏ö‡∏ö‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥" ‡πÄ‡∏•‡∏¢! ‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤‡πÄ‡∏´‡∏•‡πà‡∏≤‡∏ô‡∏µ‡πâ‡∏à‡∏∞‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ "‡∏à‡∏±‡∏ö" ‡∏´‡∏£‡∏∑‡∏≠ "‡∏ö‡∏•‡πá‡∏≠‡∏Å" ‡∏™‡∏≤‡∏£‡∏ö‡∏≤‡∏á‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÉ‡∏ô‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡πÄ‡∏£‡∏≤‡∏ó‡∏µ‡πà‡∏Å‡∏≥‡∏•‡∏±‡∏á‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏ú‡∏¥‡∏î‡∏õ‡∏Å‡∏ï‡∏¥‡πÅ‡∏•‡∏∞‡∏Å‡πà‡∏≠‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏¥‡∏î‡∏Å‡∏≤‡∏£‡∏≠‡∏±‡∏Å‡πÄ‡∏™‡∏ö‡πÉ‡∏ô‡∏õ‡∏≠‡∏î ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏≠‡∏±‡∏Å‡πÄ‡∏™‡∏ö‡∏´‡∏¢‡∏∏‡∏î‡∏•‡∏á ‡∏´‡∏£‡∏∑‡∏≠‡∏•‡∏î‡∏•‡∏á‡πÑ‡∏î‡πâ‡πÇ‡∏î‡∏¢‡∏ï‡∏£‡∏á‡πÅ‡∏•‡∏∞‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥‡∏ó‡∏µ‡πà‡∏™‡∏∏‡∏î‡∏Ñ‡πà‡∏∞üéØ&nbsp;‡∏î‡∏±‡∏á‡∏ô‡∏±‡πâ‡∏ô... ‡∏¢‡∏≤‡∏ó‡∏∏‡∏Å‡∏ï‡∏±‡∏ß‡∏ó‡∏µ‡πà‡∏•‡∏á‡∏ó‡πâ‡∏≤‡∏¢‡∏î‡πâ‡∏ß‡∏¢ "-mab" ‡∏Å‡πá‡∏Ñ‡∏∑‡∏≠ ‡∏¢‡∏≤‡πÉ‡∏ô‡∏Å‡∏•‡∏∏‡πà‡∏° Monoclonal Antibody ‡∏ó‡∏µ‡πà‡∏≠‡∏≠‡∏Å‡∏§‡∏ó‡∏ò‡∏¥‡πå‡πÅ‡∏ö‡∏ö "‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤" ‡πÑ‡∏õ‡∏¢‡∏±‡∏á‡πÄ‡∏õ‡πâ‡∏≤‡∏´‡∏°‡∏≤‡∏¢‡πÄ‡∏î‡∏µ‡∏¢‡∏ß‡∏ó‡∏µ‡πà‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡πÄ‡∏à‡∏≤‡∏∞‡∏à‡∏á‡∏ô‡∏±‡πà‡∏ô‡πÄ‡∏≠‡∏á‡∏Ñ‡πà‡∏∞!üéØ&nbsp;‡∏ï‡∏±‡∏ß‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏¢‡∏≤ "‡πÅ‡∏°‡∏ö‡πÜ" ‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡∏Ñ‡∏∏‡∏¢‡∏Å‡∏±‡∏ô‡πÑ‡∏õ‡πÅ‡∏•‡πâ‡∏ß:‚úÖ Omalizumab (‡πÇ‡∏≠‡∏°‡∏≤‡∏•‡∏¥‡∏ã‡∏π‡πÅ‡∏°‡∏ö)‚úÖ Mepolizumab (‡∏°‡∏µ‡πÇ‡∏û‡∏•‡∏¥‡∏ã‡∏π‡πÅ‡∏°‡∏ö)‚úÖ Reslizumab (‡πÄ‡∏£‡∏™‡∏•‡∏¥‡∏ã‡∏π‡πÅ‡∏°‡∏ö)‚úÖ Benralizumab (‡πÄ‡∏ö‡∏ô‡∏£‡∏≤‡∏•‡∏¥‡∏ã‡∏π‡πÅ‡∏°‡∏ö)‚úÖ Dupilumab (‡∏î‡∏π‡∏û‡∏¥‡∏•‡∏π‡πÅ‡∏°‡∏ö)‚úÖ Tezepelumab (‡πÄ‡∏ó‡πÄ‡∏ã‡πÄ‡∏û‡∏•‡∏π‡πÅ‡∏°‡∏ö)üòÜ‡πÄ‡∏´‡πá‡∏ô‡πÑ‡∏´‡∏°‡∏Ñ‡∏∞‡∏ß‡πà‡∏≤ "‡πÅ‡∏°‡∏ö‡πÜ" ‡πÑ‡∏°‡πà‡πÉ‡∏ä‡πà‡πÅ‡∏Ñ‡πà‡∏ä‡∏∑‡πà‡∏≠‡πÄ‡∏ó‡πà‡πÜ ‡πÅ‡∏ï‡πà‡πÄ‡∏õ‡πá‡∏ô‡∏ä‡∏∑‡πà‡∏≠‡∏ó‡∏µ‡πà‡∏ö‡πà‡∏á‡∏ö‡∏≠‡∏Å‡∏ñ‡∏∂‡∏á‡∏Å‡∏•‡πÑ‡∏Å‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏≠‡∏±‡∏ô‡∏ä‡∏≤‡∏ç‡∏â‡∏•‡∏≤‡∏î‡∏Ç‡∏≠‡∏á‡∏¢‡∏≤‡πÄ‡∏´‡∏•‡πà‡∏≤‡∏ô‡∏µ‡πâ‡πÄ‡∏•‡∏¢! ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î‡πÑ‡∏î‡πâ‡∏ú‡∏•‡∏î‡∏µ ‡∏ï‡∏£‡∏á‡∏à‡∏∏‡∏î ‡πÅ‡∏•‡∏∞‡∏≠‡∏≤‡∏à‡∏•‡∏î‡∏ú‡∏•‡∏Ç‡πâ‡∏≤‡∏á‡πÄ‡∏Ñ‡∏µ‡∏¢‡∏á‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡πà‡∏≠‡∏£‡πà‡∏≤‡∏á‡∏Å‡∏≤‡∏¢‡πÑ‡∏î‡πâ‡∏Ñ‡πà‡∏∞üëâ‡∏´‡∏ß‡∏±‡∏á‡∏ß‡πà‡∏≤‡∏ó‡∏∏‡∏Å‡∏Ñ‡∏ô‡∏à‡∏∞‡πÄ‡∏Ç‡πâ‡∏≤‡πÉ‡∏à‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Ç‡∏≠‡∏á‡∏Ñ‡∏≥‡∏ß‡πà‡∏≤ "‡πÅ‡∏°‡∏ö‡πÜ" ‡∏Å‡∏±‡∏ô‡∏°‡∏≤‡∏Å‡∏Ç‡∏∂‡πâ‡∏ô‡∏ô‡∏∞‡∏Ñ‡∏∞! ‡πÉ‡∏Ñ‡∏£‡∏°‡∏µ‡∏Ñ‡∏≥‡∏ñ‡∏≤‡∏°‡πÄ‡∏û‡∏¥‡πà‡∏°‡πÄ‡∏ï‡∏¥‡∏° ‡∏´‡∏£‡∏∑‡∏≠‡∏≠‡∏¢‡∏≤‡∏Å‡πÉ‡∏´‡πâ‡∏°‡∏¥‡∏™‡∏´‡∏≤‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏≠‡∏∞‡πÑ‡∏£‡∏≠‡∏µ‡∏Å ‡∏Ñ‡∏≠‡∏°‡πÄ‡∏°‡∏ô‡∏ï‡πå‡∏°‡∏≤‡∏ö‡∏≠‡∏Å‡∏Å‡∏±‡∏ô‡πÑ‡∏î‡πâ‡πÄ‡∏•‡∏¢‡∏Ñ‡πà‡∏∞! üëáüíã ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏£‡∏≤‡∏ß‡∏î‡∏µ‡πÜ ‡πÅ‡∏•‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏õ‡∏£‡∏∞‡πÇ‡∏¢‡∏ä‡∏ô‡πå‡∏à‡∏≤‡∏Å‡∏°‡∏¥‡∏™‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î‡πÑ‡∏î‡πâ‡∏ó‡∏µ‡πà‡πÄ‡∏û‡∏à&nbsp;üíã @‡∏°‡∏¥‡∏™‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î - Miss Asthma Thailand&nbsp;‡∏´‡∏£‡∏∑‡∏≠‡∏≠‡πà‡∏≤‡∏ô‡∏ö‡∏ó‡∏Ñ‡∏ß‡∏≤‡∏°‡∏¢‡πâ‡∏≠‡∏ô‡∏´‡∏•‡∏±‡∏á‡πÑ‡∏î‡πâ‡∏ó‡∏µ‡πàüëâ https://missasthmath.blogspot.com&nbsp;#‡∏¢‡∏≤‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏õ‡πâ‡∏≤‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏î #MonoclonalAntibody #Mab #PrecisionMedicine #‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥ #MissAsthmaTH #‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏π‡πâ‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏¢‡∏≤ #‡∏´‡∏≠‡∏ö‡∏´‡∏∑‡∏îüìö ‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á- Ridolo E, Pucciarini F, Nizi MC, Makri E, Kihlgren P, Panella L, Incorvaia C. Mabs for treating asthma: omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab. Hum Vaccin Immunother. 2020 Oct 2;16(10):2349-2356. doi: 10.1080/21645515.2020.1753440. Epub 2020 May 13. PMID: 32401603; PMCID: PMC7644228.-&nbsp;American Medical Association (AMA):&nbsp;guidance on naming monoclonal antibodies&nbsp;- WHO:&nbsp;New INN monoclonal antibody (mAb) nomenclature scheme (May 2022)&nbsp;]]></summary></entry><entry><title type="html">R.I.P David Baltimore - Noble Laureate 1975</title><link href="https://kuchikinamthip.github.io/blog/2025/rip-david-baltimore-noble-laureate-1975/" rel="alternate" type="text/html" title="R.I.P David Baltimore - Noble Laureate 1975"/><published>2025-09-13T11:32:00+00:00</published><updated>2025-09-13T11:32:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/rip-david-baltimore---noble-laureate-1975</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/rip-david-baltimore-noble-laureate-1975/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;R.I.P. Prof. David BaltimoreNobel Laureate in Physiology/Medicine (1975) ‚Äî discoverer of the enzyme Reverse Transcriptase (RT) in 1970, at just 37 years old.This enzyme has been in every high-school biology textbook, yet many of us forget how revolutionary its discovery was.It changed the way we understand life, disease, and treatment.At that time, the Central Dogma was simple:DNA ‚Üí RNA ‚Üí Protein.But RT overturned the dogma: RNA ‚Üí DNA.A paradigm shift.Baltimore‚Äôs experiment explained how viruses could integrate their genetic material into the host DNA. Later, this became central to our understanding of HIV, cancer biology, and the development of therapies.His discovery also sparked the golden era of viral oncogenes ‚Äî genes like src and myc carried by viruses that could integrate into human DNA and trigger cancer.I was fortunate to join a seminar earlier this year where Prof. Baltimore gave a keynote talk at Cold Spring Harbor Laboratory (Cancer Genetics: History &amp; Consequences)That took us on a journey: from discovering RT, to viral oncogenes, to targeted therapy, to the human genome project, and finally, to the age of AI.Science is like a staircase.We climb higher by standing on the steps built by those before us.We honor, respect, and cite their work ‚Äî and that‚Äôs why science is beautiful.]]></summary></entry><entry><title type="html">‡πÇ‡∏£‡∏°‡∏¥‡πÇ‡∏≠‡∏à‡∏π‡∏à‡∏∏‡πä‡∏ö‡∏•‡∏π‡πÄ‡∏•‡∏µ‡∏¢‡∏ïüíã ‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡∏±‡∏ö‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á</title><link href="https://kuchikinamthip.github.io/blog/2025/no-cancer-th-blog-post_12.html/" rel="alternate" type="text/html" title="‡πÇ‡∏£‡∏°‡∏¥‡πÇ‡∏≠‡∏à‡∏π‡∏à‡∏∏‡πä‡∏ö‡∏•‡∏π‡πÄ‡∏•‡∏µ‡∏¢‡∏ïüíã ‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡∏±‡∏ö‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á"/><published>2025-09-12T09:36:00+00:00</published><updated>2025-09-12T09:36:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/no-cancer-th-blog-post_12.html</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/no-cancer-th-blog-post_12.html/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[‡πÇ‡∏£‡∏°‡∏¥‡πÇ‡∏≠‡∏à‡∏π‡∏à‡∏∏‡πä‡∏ö‡∏•‡∏π‡πÄ‡∏•‡∏µ‡∏¢‡∏ï&nbsp;üíã&nbsp;‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡∏±‡∏ö‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á&nbsp;‡∏õ‡∏Å‡∏ß‡∏≤‡∏£‡∏™‡∏≤‡∏£ Cancer Cell ‡∏â‡∏ö‡∏±‡∏ö‡∏ô‡∏µ‡πâ ‡∏ô‡∏∂‡∏Å‡∏ß‡πà‡∏≤‡∏ô‡∏¥‡∏¢‡∏≤‡∏¢‡∏£‡∏±‡∏Å‡∏Å‡∏Å‡∏Å‡∏Å‡∏°‡∏±‡∏ô‡∏Ñ‡∏∑‡∏≠‡∏â‡∏≤‡∏Å‡∏≠‡∏°‡∏ï‡∏∞‡∏ó‡∏µ‡πà‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏á‡∏ã‡∏∂‡πà‡∏á‡πÇ‡∏£‡∏°‡∏¥‡πÇ‡∏≠‡∏Å‡∏±‡∏ö‡∏à‡∏π‡πÄ‡∏•‡∏µ‡∏¢‡∏ï‡∏à‡∏π‡∏ö‡∏Å‡∏±‡∏ô‡∏ô‡∏ô‡∏ô‡∏ô‡∏´‡∏ß‡∏≤‡∏ô‡∏ï‡∏±‡∏î‡∏Ç‡∏≤ ‡∏ï‡∏π‡πâ‡∏ß‡∏´‡∏π‡∏ß‡∏ß‡∏ß‡∏ß.‡πÅ‡∏ï‡πà‡πÜ ‡πÅ‡∏•‡πâ‡∏ß‡∏°‡∏±‡∏ô‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡∏±‡∏ö‡∏ß‡∏≤‡∏£‡∏™‡∏≤‡∏£‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á‡∏≠‡πà‡∏∞‡πÅ‡∏Å‡∏õ‡∏Å‡∏ô‡∏µ‡πâ‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏°‡∏≤‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏à‡∏∞‡∏™‡∏∑‡πà‡∏≠‡∏ñ‡∏∂‡∏á‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏ä‡∏¥‡πâ‡∏ô‡∏ô‡∏∂‡∏á‡πÉ‡∏ô‡∏â‡∏ö‡∏±‡∏ö‡∏ô‡∏µ‡πâ‡∏ä‡∏∑‡πà‡∏≠ "Gene context drift identifies drug targets to mitigate cancer treatment resistance"‡∏°‡∏±‡∏ô‡∏ß‡πà‡∏≤‡∏î‡πâ‡∏ß‡∏¢‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏ö‡∏£‡∏¥‡∏ö‡∏ó‡∏Ç‡∏≠‡∏á‡∏¢‡∏µ‡∏ô‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡∏±‡∏ß‡∏ö‡∏≠‡∏Å‡∏ó‡∏∏‡∏Å‡∏™‡∏¥‡πà‡∏á‡∏Ñ‡∏∑‡∏≠‡∏á‡∏≤‡∏ô‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡πÑ‡∏´‡∏ô‡πÅ‡∏ï‡πà‡πÑ‡∏£‡∏°‡∏≤ ‡πÄ‡∏£‡∏≤‡∏°‡∏±‡∏Å‡∏à‡∏∞‡∏î‡∏π‡∏¢‡∏µ‡∏ô‡πÅ‡∏Ñ‡πà‡∏¢‡∏µ‡∏ô‡πÄ‡∏î‡∏µ‡∏¢‡∏ß‡πÅ‡∏ï‡πà‡∏û‡∏±‡∏Å‡∏´‡∏•‡∏±‡∏á‡∏á‡∏≤‡∏ô‡πÄ‡∏£‡∏¥‡πà‡∏°‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏°‡∏≤‡∏î‡∏π‡∏´‡∏•‡∏≤‡∏¢‡πÜ‡∏¢‡∏µ‡∏ô‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏Å‡∏±‡∏ô‡∏ã‡∏∂‡πà‡∏á‡∏Å‡πá‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡∏ö‡∏£‡∏¥‡∏ö‡∏ó‡πÇ‡∏î‡∏¢‡∏£‡∏ß‡∏° (gene context)‡∏á‡∏≤‡∏ô‡∏ß‡∏¥‡∏à‡∏±‡∏¢‡∏ô‡∏µ‡πâ‡∏Å‡πá‡πÄ‡∏õ‡πá‡∏ô‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏ö‡∏£‡∏¥‡∏ö‡∏ó‡∏Ç‡∏≠‡∏á‡∏ä‡∏≤‡∏ß‡πÅ‡∏Å‡πä‡∏á‡∏Ñ‡πå‡∏¢‡∏µ‡∏ô‡∏ô‡∏µ‡πà‡πÅ‡∏´‡∏•‡∏∞‡∏ó‡∏µ‡πà‡∏°‡∏≤‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Ç‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏î‡∏∑‡πâ‡∏≠‡∏¢‡∏≤‡∏Ç‡∏≠‡∏á‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏áGene'll never work(walk) alone!‡∏ã‡∏∂‡πà‡∏á‡πÄ‡∏Ñ‡πâ‡∏≤‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏£‡∏π‡∏õ‡∏â‡∏≤‡∏Å‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏á‡∏ô‡∏µ‡πâ‡∏°‡∏≤‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏â‡∏≤‡∏Å‡∏≠‡∏°‡∏ï‡∏∞‡∏Ñ‡∏∑‡∏≠‡∏ñ‡πâ‡∏≤‡πÄ‡∏õ‡∏£‡∏µ‡∏¢‡∏ö‡πÄ‡∏ó‡∏µ‡∏¢‡∏ö‡∏Å‡∏±‡∏ö‡∏ô‡∏¥‡∏¢‡∏≤‡∏¢‡πÑ‡∏ó‡∏¢‡∏≠‡∏≤‡∏à‡∏à‡∏∞‡πÅ‡∏ö‡∏ö‡πÇ‡∏Å‡πÇ‡∏ö‡∏£‡∏¥‡∏Å‡∏±‡∏ö‡∏≠‡∏±‡∏á‡∏®‡∏∏‡∏°‡∏≤‡∏•‡∏¥‡∏ô ‡∏£‡∏±‡∏Å‡∏ó‡πà‡∏≤‡∏°‡∏Å‡∏•‡∏≤‡∏á‡∏™‡∏á‡∏Ñ‡∏£‡∏≤‡∏°‡πÑ‡∏£‡∏á‡∏µ‡πâ 5555‡∏´‡∏£‡∏∑‡∏≠‡πÑ‡∏£‡∏≠‡∏µ‡∏Å ‡∏â‡∏≤‡∏Å‡πÉ‡∏ï‡πâ‡∏ñ‡∏∏‡∏ô ‡πÅ‡∏°‡πà‡∏ô‡∏≤‡∏Ñ‡∏¢‡∏∑‡πà‡∏ô‡∏°‡∏∑‡∏≠‡πÄ‡∏Å‡πá‡∏ö‡∏°‡∏∞‡∏ô‡∏≤‡∏ß‡∏Ñ‡∏∑‡∏≠‡πÄ‡∏´‡πá‡∏ô‡πÅ‡∏ö‡∏ö‡∏ô‡∏∂‡∏Å‡∏≠‡∏≠‡∏Å‡πÄ‡∏•‡∏¢‡∏ß‡πà‡∏≤‡∏á‡∏±‡πâ‡∏ô#NoCancer]]></summary></entry><entry><title type="html">R.I.P. ‡∏®.‡∏î‡∏£.‡πÄ‡∏î‡∏ß‡∏¥‡∏î ‡∏ö‡∏±‡∏•‡∏ï‡∏¥‡∏°‡∏≠‡∏£‡πå ‡∏ú‡∏π‡πâ‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå Reverse Transcriptase</title><link href="https://kuchikinamthip.github.io/blog/2025/rip-reverse-transcriptase/" rel="alternate" type="text/html" title="R.I.P. ‡∏®.‡∏î‡∏£.‡πÄ‡∏î‡∏ß‡∏¥‡∏î ‡∏ö‡∏±‡∏•‡∏ï‡∏¥‡∏°‡∏≠‡∏£‡πå ‡∏ú‡∏π‡πâ‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå Reverse Transcriptase"/><published>2025-09-11T11:14:00+00:00</published><updated>2025-09-11T11:14:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/rip----reverse-transcriptase</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/rip-reverse-transcriptase/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;R.I.P. ‡∏®.‡∏î‡∏£.‡πÄ‡∏î‡∏ß‡∏¥‡∏î ‡∏ö‡∏±‡∏•‡∏ï‡∏¥‡∏°‡∏≠‡∏£‡πå‡πÄ‡∏à‡πâ‡∏≤‡∏Ç‡∏≠‡∏á‡∏£‡∏≤‡∏á‡∏ß‡∏±‡∏•‡πÇ‡∏ô‡πÄ‡∏ö‡∏• 1975‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå Reverse Transcriptase (RT) ‡πÉ‡∏ô‡∏õ‡∏µ 1970 ‡∏ï‡∏≠‡∏ô‡∏≠‡∏≤‡∏¢‡∏∏‡πÅ‡∏Ñ‡πà 37 ‡∏õ‡∏µ.‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå‡∏ô‡∏µ‡πâ‡∏ñ‡∏π‡∏Å‡∏ö‡∏£‡∏£‡∏à‡∏∏‡∏•‡∏á‡∏´‡∏ô‡∏±‡∏á‡∏™‡∏∑‡∏≠‡πÄ‡∏£‡∏µ‡∏¢‡∏ô ‡∏°.‡∏õ‡∏•‡∏≤‡∏¢ ‡πÑ‡∏õ‡∏à‡∏ô‡πÄ‡∏£‡∏≤‡∏•‡∏∞‡πÄ‡∏•‡∏¢‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡πÇ‡∏•‡∏Å‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ô‡∏µ‡πâ‡πÑ‡∏õ‡πÄ‡∏•‡∏¢.‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ô‡∏µ‡πâ‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Ç‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡πÄ‡∏Ç‡πâ‡∏≤‡πÉ‡∏à‡πÇ‡∏£‡∏Ñ‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡πÜ‡∏≠‡∏¢‡πà‡∏≤‡∏á HIV, ‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á ‡πÅ‡∏•‡∏∞‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏µ‡πà‡∏°‡∏≤‡∏Ç‡∏≠‡∏á‡∏¢‡∏≤‡∏î‡πâ‡∏ß‡∏¢.‡∏ì ‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô ‡πÄ‡∏£‡∏≤‡∏£‡∏π‡πâ‡∏à‡∏±‡∏Å Central dogma ‡∏Ñ‡∏∑‡∏≠‡∏à‡∏≤‡∏Å DNA -&gt; RNA -&gt; Protein‡πÅ‡∏ï‡πà RT ‡∏Ñ‡∏∑‡∏≠‡∏™‡∏¥‡πà‡∏á‡∏™‡∏ß‡∏ô‡∏ó‡∏≤‡∏á‡∏ä‡πà‡∏ß‡∏¢‡πÉ‡∏´‡πâ‡∏à‡∏≤‡∏Å RNA -&gt; DNA‡πÄ‡∏£‡∏µ‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏Ñ‡∏ß‡πà‡∏≥‡∏Å‡∏£‡∏∞‡∏î‡∏≤‡∏ô‡πÄ‡∏Å‡πà‡∏≤‡πÄ‡∏•‡∏¢.‡∏Å‡∏≤‡∏£‡∏ó‡∏î‡∏•‡∏≠‡∏á‡∏ï‡∏≠‡∏ô‡∏ô‡∏±‡πâ‡∏ô‡∏Ñ‡∏∑‡∏≠ ‡πÄ‡∏Ñ‡πâ‡∏≤‡∏£‡∏π‡πâ‡∏Å‡∏±‡∏ô‡πÅ‡∏•‡πâ‡∏ß‡∏ß‡πà‡∏≤‡πÑ‡∏ß‡∏£‡∏±‡∏™‡∏°‡∏±‡∏ô‡∏ù‡∏±‡∏á‡∏ï‡∏±‡∏ß‡πÄ‡∏Ç‡πâ‡∏≤‡πÑ‡∏õ‡∏ö‡∏ô‡∏û‡∏±‡∏ô‡∏ò‡∏∏‡∏Å‡∏£‡∏£‡∏°(DNA) ‡∏Ç‡∏≠‡∏á‡πÇ‡∏Æ‡∏™‡πÑ‡∏î‡πâ&nbsp;‡πÅ‡∏ï‡πà‡∏¢‡∏±‡∏á‡πÑ‡∏°‡πà‡∏£‡∏π‡πâ‡∏ß‡πà‡∏≤‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡πÑ‡∏î‡πâ‡∏ô‡∏µ‡πà ‡∏ó‡∏≥‡πÄ‡∏Ç‡πâ‡∏≤‡∏≠‡∏µ‡∏ó‡πà‡∏≤‡πÑ‡∏´‡∏ô‡∏Å‡∏≤‡∏£‡∏û‡∏¥‡∏™‡∏π‡∏à‡∏ô‡πå‡∏Å‡πá‡πÄ‡∏•‡∏¢‡∏°‡∏≤‡πÄ‡∏à‡∏≠‡πÄ‡∏≠‡∏°‡πÑ‡∏ã‡∏°‡πå‡∏ï‡∏±‡∏ß‡∏ô‡∏µ‡πâ.‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡πÇ‡∏£‡∏Ñ HIV ‡∏Ñ‡∏∑‡∏≠‡πÇ‡∏£‡∏Ñ‡∏Ç‡∏≠‡∏á‡πÑ‡∏ß‡∏£‡∏±‡∏™‡∏Å‡πá‡∏û‡∏≠‡πÄ‡∏Ç‡πâ‡∏≤‡πÉ‡∏à‡πÑ‡∏î‡πâ‡πÅ‡∏•‡πâ‡∏ß‡∏°‡∏±‡∏ô‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏≠‡∏∞‡πÑ‡∏£‡∏Å‡∏±‡∏ö‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á?.‡∏ñ‡∏±‡∏î‡∏à‡∏≤‡∏Å‡∏ó‡∏µ‡πà Prof. ‡∏ö‡∏±‡∏•‡∏ï‡∏¥‡∏°‡∏≠‡∏£‡πå ‡πÄ‡∏à‡∏≠‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå‡∏ï‡∏±‡∏ß‡∏ô‡∏µ‡πâ‡∏Å‡πá‡πÄ‡∏õ‡πá‡∏ô‡∏¢‡∏∏‡∏Ñ‡∏£‡∏∏‡πà‡∏á‡πÄ‡∏£‡∏∑‡∏≠‡∏á‡∏Ç‡∏≠‡∏á‡∏¢‡∏µ‡∏ô‡∏™‡πå‡∏Å‡πà‡∏≠‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á‡∏ó‡∏µ‡πà‡∏≠‡∏¢‡∏π‡πà‡πÉ‡∏ô‡πÑ‡∏ß‡∏£‡∏±‡∏™ (viral oncogene)‡∏Ñ‡∏∑‡∏≠‡πÑ‡∏ß‡∏£‡∏±‡∏™‡∏°‡∏±‡∏ô‡∏Å‡πà‡∏≠‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á‡πÑ‡∏î‡πâ ‡πÄ‡∏ä‡πà‡∏ô myc, src&nbsp;‡πÇ‡∏î‡∏¢‡πÄ‡∏≠‡∏≤‡∏¢‡∏µ‡∏ô‡∏™‡πå‡∏û‡∏ß‡∏Å‡∏ô‡∏µ‡πâ‡∏°‡∏≤‡∏õ‡∏±‡∏Å‡πÉ‡∏™‡πà‡∏Ñ‡∏ô‡∏ß‡πà‡∏≤‡∏á‡∏±‡πâ‡∏ô ‡∏õ‡∏±‡∏Å‡∏õ‡∏∏‡πä‡∏ö‡∏ù‡∏±‡∏á‡πÄ‡∏Ç‡πâ‡∏≤‡∏û‡∏±‡∏ô‡∏ò‡∏∏‡∏Å‡∏£‡∏£‡∏°‡∏Ñ‡∏ô‡∏õ‡∏±‡πä‡∏ö ‡πÄ‡∏õ‡πá‡∏ô‡∏°‡∏∞‡πÄ‡∏£‡πá‡∏á‡∏Ç‡∏∂‡πâ‡∏ô‡∏°‡∏≤.‡πÄ‡∏û‡∏¥‡πà‡∏á‡πÄ‡∏Ç‡πâ‡∏≤‡∏£‡πà‡∏ß‡∏°‡∏™‡∏±‡∏°‡∏ô‡∏≤‡∏ó‡∏µ‡πà Prof. ‡∏°‡∏≤‡πÄ‡∏õ‡πá‡∏ô keynote ‡πÄ‡∏°‡∏∑‡πà‡∏≠‡∏ï‡πâ‡∏ô‡∏õ‡∏µ‡∏°‡∏±‡∏ô‡πÄ‡∏õ‡πá‡∏ô‡∏á‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡∏™‡∏ô‡∏∏‡∏Å‡∏°‡∏≤‡∏Å‡πÄ‡∏£‡∏∑‡πà‡∏≠‡∏á‡∏£‡∏≤‡∏ß‡∏Ç‡∏≠‡∏á talk ‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡πÑ‡∏•‡πà‡∏°‡∏≤‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà‡∏ó‡∏µ‡πà‡∏Ñ‡πâ‡∏ô‡∏û‡∏ö‡πÄ‡∏≠‡∏ô‡πÑ‡∏ã‡∏°‡πå RT‡∏ï‡πà‡∏≠‡∏ó‡∏µ‡πà oncogene ‡∏¢‡∏≤‡∏ß‡πÑ‡∏õ‡∏ñ‡∏∂‡∏á targeted therapy ‡∏ï‡πà‡∏≠‡∏ó‡∏µ‡πà human genome ‡πÅ‡∏•‡πâ‡∏ß‡∏à‡∏ö‡∏ó‡∏µ‡πà‡∏¢‡∏∏‡∏Ñ AI.‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏Å‡πá‡πÄ‡∏´‡∏°‡∏∑‡∏≠‡∏ô‡∏Ç‡∏±‡πâ‡∏ô‡∏ö‡∏±‡∏ô‡πÑ‡∏î&nbsp;‡∏ó‡∏µ‡πà‡πÄ‡∏£‡∏≤‡∏ï‡πà‡∏≠‡∏¢‡∏≠‡∏î‡∏à‡∏≤‡∏Å‡∏™‡∏¥‡πà‡∏á‡∏ó‡∏µ‡πà‡∏Ñ‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏à‡∏≠‡πÄ‡∏Ñ‡∏≤‡∏£‡∏û ‡πÉ‡∏´‡πâ‡πÄ‡∏Å‡∏µ‡∏¢‡∏£‡∏ï‡∏¥ ‡πÅ‡∏•‡∏∞‡∏≠‡πâ‡∏≤‡∏á‡∏ñ‡∏∂‡∏á‡πÉ‡∏ô‡∏ú‡∏•‡∏á‡∏≤‡∏ô‡∏Ç‡∏≠‡∏á‡πÄ‡∏£‡∏≤‡πÄ‡∏û‡∏£‡∏≤‡∏∞‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏ô‡∏µ‡πâ‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏à‡∏∂‡∏á‡∏™‡∏ß‡∏¢‡∏á‡∏≤‡∏°‡∏Ç‡∏≠‡∏ö‡∏Ñ‡∏∏‡∏ì ‡∏®.‡∏î‡∏£.‡πÄ‡∏î‡∏ß‡∏¥‡∏î ‡∏ö‡∏±‡∏•‡∏ï‡∏¥‡∏°‡∏≠‡∏£‡πå ‡∏ó‡∏µ‡πà‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏ö‡∏±‡∏ô‡πÑ‡∏î‡∏Ç‡∏±‡πâ‡∏ô‡πÅ‡∏£‡∏á‡πÑ‡∏ß‡πâ‡πÉ‡∏´‡πâ‡∏û‡∏ß‡∏Å‡πÄ‡∏£‡∏≤‡∏ô‡∏±‡∏Å‡∏ß‡∏¥‡∏ó‡∏¢‡∏≤‡∏®‡∏≤‡∏™‡∏ï‡∏£‡πå‡∏£‡∏∏‡πà‡∏ô‡∏´‡∏•‡∏±‡∏á R.I.P.]]></summary></entry><entry><title type="html">üíäThe Infinity Cancer Drug Factory üèØ‚ú®</title><link href="https://kuchikinamthip.github.io/blog/2025/the-infinity-cancer-drug-factory/" rel="alternate" type="text/html" title="üíäThe Infinity Cancer Drug Factory üèØ‚ú®"/><published>2025-09-11T08:02:00+00:00</published><updated>2025-09-11T08:02:00+00:00</updated><id>https://kuchikinamthip.github.io/blog/2025/the-infinity-cancer-drug-factory-</id><content type="html" xml:base="https://kuchikinamthip.github.io/blog/2025/the-infinity-cancer-drug-factory/"><![CDATA[]]></content><author><name></name></author><summary type="html"><![CDATA[&nbsp;üíä The Infinity Cancer Drug Factory üèØ‚ú®&nbsp; Pharmacy students don‚Äôt just learn about medicines ‚Äî we also have to design factory layouts‚Ä¶ even though most of us can‚Äôt use AutoCAD properly üòÇ Designing a pharmaceutical plant layout is never simple. üè≠ For a regular drug factory, you already need a complex flow to separate cleanroom grades and prevent contamination. ‚ö†Ô∏è For chemotherapy drugs (cytotoxic), the complexity increases ‚Äî you must protect workers and contain hazardous substances. üß¨ For biologics, you add another layer: biosafety. It becomes so complicated that it feels like Infinity Castle from Demon Slayer ‚Äî you can enter, but finding the way out is impossible üòÖ. üí° Back in pharmacy school, we had to design plant layouts too: Some friends got simple factories (like paracetamol) ‚Üí easy task üòå My group drew a chemotherapy factory ‚Üí endless books and regulations üìö My close friend got a vaccine factory ‚Üí even harder, with design + legal compliance Our layout followed every rule perfectly. The professor gave only one comment: üëâ ‚ÄúYou can enter, but it‚Äôs like a maze‚Ä¶ no way out.‚Äù ü§£ üö™ Later, I did an internship at a real biologics manufacturing site. Once inside, it truly felt like another dimension. Without senior staff guiding me, I probably would‚Äôve been lost crying at the airlock ü§≠. üìå For those interested: there are specialized graduate programs combining Pharmacy + Engineering, focusing on pharmaceutical plant design, GMP, air-handling, and regulatory compliance. It‚Äôs not just ‚Äúdesign‚Äù ‚Äî mistakes here can have real-world consequences. üëâ Have you ever felt lost in a workplace layout that felt like an Infinity Castle? üòÜ #BoundlessDrugFactory #InfinityCastlePharma #PharmaLife #GMP #PharmaEngineering #PharmaceuticalSciences #Biologics #CytotoxicDrugs #DrugFactoryMaze]]></summary></entry></feed>